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Abstract
Modern clinical applications require precise positional and temporal information regarding pathological
changes in cells and tissues. For example, in magnetic resonance microscopy, better than 100 sq. micros per
voxel spatial resolution is necessary for imaging capillary blood vessels. And in order to monitor the blood
flows in brain tissues, a series of images must be acquired in less than 2 s intervals. Further, molecular imaging
aims at visualizing molecules and molecular events that occur at a cellular level, i.e. sensing biological events at
a fundamentally microscopic level. When compared to other imaging modalities, the main advantages of
magnetic resonance imaging (MRI) are its millimeter-scale spatial resolution and wide applicability achieved
with minimal perturbation to in vivo systems, whereas its major drawbacks are limited sensitivity (10 protons
in a million contribute to magnetic resonance) and high cost (a million US dollars each MRI scanner). One
promising solution to both problems is the combination of hyperpolarized 129Xe MRI with biosensors,
which offers significant sensitivity enhancement at a much lower cost.
This dissertation reports my progress in hyperpolarized 129Xe nuclear magnetic resonance (NMR) studies
for use in future molecular/medical MRI applications. First, I provide an overview of molecular imaging and,
specifically, magnetic resonance imaging (MRI). 129Xe NMR/MRI is particularly promising as it solves
solves the common problems of signal intensity and specificity (by employing biosensors).
In chapter 2, I present our hyperpolarization (nuclear spin polarization) method. A hyperpolarized 129Xe
chemical exchange saturation transfer (Hyper-CEST) method was also applied to lower the biosensor
detection limits significantly. These experiments were made possible through the development of a home-
built 129Xe hyperpolarizer, continuous-flow hyperpolarized Xe delivery setup, Hyper-CEST pulse sequence,
and accompanying NMR control programs.
In chapter 3, interactions between various biosensors and their target proteins have been characterized and
analyzed in finer detail than previous studies. 129Xe NMR studies for biosensors targeting human carbonic
anhydrase, alpha_{v}beta_{3} integrin, and pH changes have been carried out.
In chapter 4, hyperpolarized 129Xe chemical exchange saturation transfer (Hyper-CEST) NMR experiments
have demonstrated unprecedented detection sensitivity for a synthetic xenon host molecule, tri-acetic acid
cryptophane.
In chapter 5, to describe interactions between xenon and bacterial spores, Hyper-CEST has been successfully
applied; Xe is demonstrated to be a good probe of the spore interior structure. Six spores strains with different
protective layers were clearly distinguished by Xe exchanges between spore and water, observed by Hyper-
CEST.
Finally, these results are summarized in chapter 6.
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ABSTRACT
APPLICATIONS OF HYPERPOLARIZED XENON-129 NMR AND
CHEMICAL EXCHANGE SATURATION TRANSFER IN BIOSENSING
Yubin Bai
Ivan J. Dmochowski
Modern clinical applications require precise positional and temporal informa-
tion regarding pathological changes in cells and tissues. For example, in magnetic
resonance microscopy, better than 100 µm3 per voxel spatial resolution is necessary
for imaging capillary blood vessels. And in order to monitor the blood flows in
brain tissues, a series of images must be acquired in less than 2 s intervals. Fur-
ther, molecular imaging aims at visualizing molecules and molecular events that
occur at a cellular level, i.e. sensing biological events at a fundamentally micro-
scopic level. When compared to other imaging modalities, the main advantages of
magnetic resonance imaging (MRI) are its millimeter-scale spatial resolution and
wide applicability achieved with minimal perturbation to in vivo systems, whereas
its major drawbacks are limited sensitivity (10 protons in a million contribute to
magnetic resonance) and high cost (a million US dollars each MRI scanner). One
promising solution to both problems is the combination of hyperpolarized 129Xe
MRI with biosensors, which offers significant sensitivity enhancement at a much
lower cost.
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This dissertation reports my progress in hyperpolarized 129Xe nuclear magnetic
resonance (NMR) studies for use in future molecular/medical MRI applications.
First, I provide an overview of molecular imaging and, specifically, magnetic reso-
nance imaging (MRI). 129Xe NMR/MRI is particularly promising as it solves solves
the common problems of signal intensity and specificity (by employing biosensors).
In chapter 2, I present our hyperpolarization (nuclear spin polarization) method.
A hyperpolarized 129Xe chemical exchange saturation transfer (Hyper-CEST) method
was also applied to lower the biosensor detection limits significantly. These exper-
iments were made possible through the development of a home-built 129Xe hy-
perpolarizer, continuous-flow hyperpolarized Xe delivery setup, Hyper-CEST pulse
sequence, and accompanying NMR control programs.
In chapter 3, interactions between various biosensors and their target proteins
have been characterized and analyzed in finer detail than previous studies. 129Xe
NMR studies for biosensors targeting human carbonic anhydrase, αvβ3 integrin,
and pH changes have been carried out.
In chapter 4, hyperpolarized 129Xe chemical exchange saturation transfer (Hyper-
CEST) NMR experiments have demonstrated unprecedented detection sensitivity
for a synthetic xenon host molecule, tri-acetic acid cryptophane.
In chapter 5, to describe interactions between xenon and bacterial spores, Hyper-
CEST has been successfully applied; Xe is demonstrated to be a good probe of
the spore interior structure. Six spores strains with different protective layers were
vi
clearly distinguished by Xe exchanges between spore and water, observed by Hyper-
CEST.
Finally, these results are summarized in chapter 6.
vii
Contents
List of Tables xiii
List of Figures xiv
1 Introduction 1
1.1 Molecular Imaging . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
1.1.1 Current Techniques for Molecular/Medical Imaging . . . . . 2
1.1.2 Magnetic Resonance Imaging (MRI) . . . . . . . . . . . . . 3
1.1.3 MRI Contrast Agents . . . . . . . . . . . . . . . . . . . . . . 4
1.1.4 Targeted MRI Contrast Agents (Biosensors) . . . . . . . . . 6
1.2 129Xe in Magnetic Resonance . . . . . . . . . . . . . . . . . . . . . 6
1.2.1 129Xe and Hyperpolarization . . . . . . . . . . . . . . . . . . 6
1.2.2 Developments Underway in 129Xe MRI . . . . . . . . . . . . 8
2 Hyperpolarized (HP) 129Xe NMR and Hyper-CEST 13
2.1 129Xe Hyperpolarization Through Optical Pumping . . . . . . . . . 14
viii
2.1.1 Nuclear Spin Polarization (Hyperpolarization) . . . . . . . . 14
2.1.2 Spin Transfer From Photons to 129Xe Nuclei . . . . . . . . . 15
2.1.3 Cryogenic Separation of Pure HP Xe . . . . . . . . . . . . . 18
2.2 Hyperpolarized 129Xe Chemical Exchange Saturation Transfer (Hyper-
CEST) NMR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
2.2.1 Chemical Exchange Saturation Transfer (CEST) in Proton MRI 20
2.2.2 Hyper-CEST with 129Xe . . . . . . . . . . . . . . . . . . . . 21
2.2.3 Hyper-CEST Radio-frequency Pulse Sequence . . . . . . . . 22
2.2.4 HP Xe Gas Delivery Control Device . . . . . . . . . . . . . . 23
3 HP 129Xe NMR of Various Cryptophane-A Derivatives 32
3.1 Cryptophanes as Effective Xe Binders . . . . . . . . . . . . . . . . . 33
3.1.1 Water-soluble Cryptophanes . . . . . . . . . . . . . . . . . . 33
3.1.2 Tri-propargyl Cryptophane and Click-reaction . . . . . . . . 34
3.2 Carbonic Anhydrase Biosensors . . . . . . . . . . . . . . . . . . . . 35
3.2.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
3.2.2 Distance Variations . . . . . . . . . . . . . . . . . . . . . . . 36
3.2.3 Stereochemistry . . . . . . . . . . . . . . . . . . . . . . . . . 37
3.2.4 Binding Sites . . . . . . . . . . . . . . . . . . . . . . . . . . 38
3.3 Integrin Biosensor . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
3.4 pH Sensor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
ix
4 Ultrasensitive Hyper-CEST NMR with TAAC 55
4.1 Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
4.2 Experimental . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
4.2.1 Materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
4.2.2 General NMR Method . . . . . . . . . . . . . . . . . . . . . 59
4.2.3 Hyper-CEST Method . . . . . . . . . . . . . . . . . . . . . . 60
4.2.4 Isothermal Titration Calorimetry (ITC) . . . . . . . . . . . 62
4.3 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . 63
4.3.1 Hyperpolarized 129Xe NMR Spectra of TAAC in Aqueous So-
lution . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
4.3.2 Ultra-sensitive Detection of TAAC . . . . . . . . . . . . . . 65
4.3.3 ITC Measurement of Xenon Binding to TAAC . . . . . . . . 66
4.3.4 Xe@TAAC NMR Line Widths at Different Temperatures . . 66
4.3.5 Xenon Exchange Lifetime Measurement . . . . . . . . . . . . 67
4.3.6 Description of HP Xe Depolarization Rate . . . . . . . . . . 68
4.3.7 Depolarization Mechanisms . . . . . . . . . . . . . . . . . . 70
4.4 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
5 Anthrax Detection and Bacterial Spore Analysis Using 129Xe Hyper-
CEST NMR 83
5.1 Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
5.2 Results and Discussions . . . . . . . . . . . . . . . . . . . . . . . . 87
x
5.2.1 Strains . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
5.2.2 Hyper-CEST Experiment with Spores . . . . . . . . . . . . . 88
5.2.3 Hyper-CEST Profile for Spores . . . . . . . . . . . . . . . . 89
5.2.4 Depolarization Rate Measurement for Spores . . . . . . . . . 90
5.2.5 Saturation Transfer Efficiency (Hyper-CEST contrast) . . . 90
5.2.6 Enhanced Hyper-CEST from Mutated Exosporium . . . . . 91
5.2.7 Enhanced Hyper-CEST from B. subtilis Spores with Coat
Defects . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
5.2.8 Possible Origin of Xenon Exchange in Spores . . . . . . . . . 92
5.3 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
5.3.1 NMR Sample Preparation . . . . . . . . . . . . . . . . . . . 94
5.3.2 Hyperpolarized 129Xe NMR Setup . . . . . . . . . . . . . . . 94
5.4 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
6 Summary 107
6.1 Biosensor Multiplexing . . . . . . . . . . . . . . . . . . . . . . . . . 108
6.2 In vivo 129Xe Hyper-CEST MRI . . . . . . . . . . . . . . . . . . . . 109
6.3 Xenon As a Useful Biophysical Probe . . . . . . . . . . . . . . . . . 110
Appendices 111
A 129Xe Hyperpolarizer Setup 112
B Pulse Sequences and Source Code 116
xi
B.1 Hyper-CEST NMR Pulse Sequence . . . . . . . . . . . . . . . . . . 117
B.2 1D EXSY NMR Pulse Sequence . . . . . . . . . . . . . . . . . . . . 118
C Experiment Control Programs 120
C.1 Hyper-CEST Profile at Different Saturation Frequencies . . . . . . 121
C.2 Hyper-CEST Depolarization Rate Contrast . . . . . . . . . . . . . . 123
C.3 Hyper-CEST Data Auto-processing Script . . . . . . . . . . . . . . 125
Bibliography 129
xii
List of Tables
3.1 Xe binding affinities for water-soluble cryptophanes . . . . . . . . . 34
4.1 Line width of 129Xe@TAAC NMR peak at various temperatures, and
estimated Xe exchange rates. . . . . . . . . . . . . . . . . . . . . . 74
5.1 Saturation transfer (ST ) efficiency and exchange signal chemical shift
for six spore strains . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
xiii
List of Figures
1.1 Gd(III)-based MRI contrast agents commonly employed in clinics . 10
1.2 Crystal structure showing a Xe biosensor binding with carbonic an-
hydrase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
1.3 Multi-channel MRI images of a mouse brain with stroke . . . . . . . 12
2.1 Comparison between thermally polarized and hyperpolarized NMR
spectra . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
2.2 Two-step spin transfer in Spin-Exchange Optical Pumping (SEOP) 26
2.3 Spin-Exchange Optical Pumping (SEOP) setup . . . . . . . . . . . 27
2.4 Temperature-dependent CEST spectra of barbituric acid solution . 28
2.5 Directly detected 129Xe spectrum of triacetic acid cryptophane-A
derivative (TAAC) . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
2.6 Hyper-CEST pulse sequence diagram . . . . . . . . . . . . . . . . . 30
2.7 HP Xe gas mixture continuous-flow delivery setup . . . . . . . . . . 31
3.1 Structure of cryptophane-A . . . . . . . . . . . . . . . . . . . . . . 43
xiv
3.2 Structure of four tri-substituted cryptophane-A derivatives . . . . . 44
3.3 Crystal structure of Xe bound to tripropargyl cryptophane-A . . . . 45
3.4 Structure of trifunctionalized cryptophane biosensors C6B, C7B, C8B,
for targeting carbonic anhydrase. . . . . . . . . . . . . . . . . . . . 46
3.5 HP 129Xe NMR spectra of benzenesulfonamide biosensors binding to
wild-type carbonic anhydrase isomers I and II . . . . . . . . . . . . 47
3.6 Structure of stereo-pure tri-substituted cryptophane-A derivatives . 48
3.7 HP 129Xe NMR spectra of stereo-pure C7B carbonic anhydrase biosen-
sor binding to wild-type carbonic anhydrase II. . . . . . . . . . . . 49
3.8 HP 129Xe NMR spectra of C8B carbonic anhydrase biosensor binding
to H94R and D19L mutants of carbonic anhydrase II. . . . . . . . . 50
3.9 Structure of αvβ3 integrin biosensor . . . . . . . . . . . . . . . . . . 51
3.10 HP 129Xe NMR spectra of αvβ3 integrin biosensor interacting with
integrin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
3.11 Structure of pH-sensitive cryptophane derived from EALA peptide . 53
3.12 HP 129Xe NMR spectra of EALA cryptophane at different pH . . . 54
4.1 Triacetic acid cryptophane-A derivative (TAAC) . . . . . . . . . . . 74
4.2 HP 129Xe NMR spectrum of 140 µM TAAC . . . . . . . . . . . . . 75
4.3 Saturation transfer processes in 129Xe Hyper-CEST NMR with cryp-
tophane. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
xv
4.4 129Xe Hyper-CEST profiles (from 3 trials) of 14 pM and 1.4 pM
TAAC at 320 K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
4.5 Enthalpogram of 3.31 mM aqueous xenon solution titrated into 131
µM TAAC solution (phosphate buffer, 20 mM, pH 7.5) at 310 K. . . 78
4.6 ITC buffer controls at 310 K. Water titrated into 20 mM phosphate
buffer, pH 7.5. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
4.7 ITC buffer controls at 310 K. Water titrated into a solution of 131
µM TAAC in 20 mM phosphate buffer, pH 7.5. . . . . . . . . . . . 80
4.8 ITC buffer controls at 310 K. Xenon-saturated water (3.31 mM)
titrated into 20 mM phosphate buffer, pH 7.5. . . . . . . . . . . . . 81
4.9 Xe-TAAC exchange lifetime measurement by selective EXSY at 297 K 82
5.1 129Xe Hyper-CEST experiment with spores . . . . . . . . . . . . . . 97
5.2 Hyper-CEST profile of wild type B. anthracis spore . . . . . . . . . 98
5.3 Hyper-CEST saturation transfer efficiency across spore strains . . . 99
5.4 Hyper-CEST profile of B. anthracis ADL2260 spores . . . . . . . . 100
5.5 Hyper-CEST profile of B. anthracis ADL986 spores . . . . . . . . . 101
5.6 Hyper-CEST profile of B. subtilis PY79 spores . . . . . . . . . . . . 102
5.7 Hyper-CEST profile of B. subtilis ADL25 spores . . . . . . . . . . . 103
5.8 Hyper-CEST data of B. subtilis ADL57 spores . . . . . . . . . . . . 104
5.9 Hyper-CEST depolarization curve of B. subtilis ADL57 spores at
1.2× 105 cfu/mL. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
xvi
A.1 Scheme of home-built 129Xe hyperpolarizer . . . . . . . . . . . . . . 113
A.2 Picture of home-built 129Xe hyperpolarizer . . . . . . . . . . . . . . 114
A.3 Pump laser absorption profile by Rb vapor . . . . . . . . . . . . . . 115
xvii
Chapter 1
Introduction
1
1.1 Molecular Imaging
1.1.1 Current Techniques for Molecular/Medical Imaging
Modern clinical applications require precise positional and temporal information of
pathological changes in cells and tissues. With the advent of minimally invasive
surgery techniques, the challenges for imaging guidance are becoming even more
demanding, especially for cancer treatments. For example, in magnetic resonance
microscopy, better than 100 µm3 per voxel spatial resolution is necessary for imag-
ing capillary blood vessels. And in order to monitor the blood flows in brain tissues,
a series of images must be acquired in less than 2 s intervals. Medical imaging seeks
to answer multiple questions once a tumor is identified, including whether the tu-
mor is malignant, where the tumor is located, the size of the tumor, whether cancer
has begun to metastasize, and whether surgical resection would impact any critical
anatomical structures. Medical imaging technologies have experienced tremendous
growth over the past few decades, and now play a central role in almost every med-
ical specialty. However, the truly revolutionary techniques that empower effective
early-stage disease diagnosis and treatment still lie in the future, when imaging will
be achieved at the molecular level.
Molecular imaging aims at visualizing molecules and molecular events that oc-
cur at a cellular level, i.e. sensing biological events at a fundamentally microscopic
level [1–4]. Currently multiple medical imaging modalities have the potential for
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molecular imaging. These include X-ray (including computed tomography, CT),
radio-pharmaceutical imaging (positron emission tomography, PET; and single-
photon emission computed tomography, SPECT), ultrasound, optical imaging (e.g.
biopsy microscopy using fluorescence, bio-luminescence, absorption or reflectance),
and magnetic resonance imaging (MRI). Each of these modalities exhibits charac-
teristic advantages and limitations for specific applications. Further, hybrid imaging
techniques, like PET-MRI, PET-CT, CT-MRI, are undergoing promising develop-
ment. The detection of disease, particularly cancer, through the coordinated use of
these techniques requires both spatial imaging of tissue and molecular imaging of
endogenous and/or artificial biomarkers.
1.1.2 Magnetic Resonance Imaging (MRI)
When compared to other imaging modalities, the main advantages of magnetic
resonance imaging (MRI) are its superb spatial resolution and wide applicability
achieved with minimal perturbation to in vivo systems, whereas its major drawbacks
are the limited sensitivity of its probes and high running cost [5].
MRI utilizes the magnetic resonance between the proton nuclear spin magnetic
moment and the applied magnetic field. The resonance frequency (Larmor fre-
quency) varies depending on the strength of an applied magnetic field and the
chemical environment of the proton under observation, the same phenomenon uti-
lized in nuclear magnetic resonance (NMR) spectroscopy. The water and lipid
3
proton resonance signals are often utilized due to the high concentration of these
species in vivo. Through the use of electromagnets within a superconducting magnet
providing magnetic polarization, field gradients can be used to encode the location
information into distinguishable resonance frequencies, and 3D images can be re-
constructed. The performance of MRI for deep tissue imaging is excellent, while
achieved with minimal invasion. Compared to CT and PET, MRI is free of radiation
hazards accumulated over many scans.
The acquisition and maintenance cost of MRI scanners is among the highest in
imaging modalities, although with good justifications. A 1.5 T (60 MHz 1H) clinical
MRI scanner currently costs ∼1 million U.S. dollars on market, not to mention the
running cost of maintaining the superconducting magnets inside. Further, while
MRI offers excellent spatial resolution, poor signal-to-noise ratios caused by the
inherent insensitivity of magnetic resonance can be problematic in data acquisition
and processing.
1.1.3 MRI Contrast Agents
The effective information in medical images is the observed contrast, which is the
difference in image brightness (signal intensity) between targets of interest and irrel-
evant background. In other words, contrast is what makes an object distinguishable
in medical images. Sources of MRI contrast include proton density, T1 relaxation, T2
relaxation, and chemical shift [5]. Contrast agents, which aim at producing higher
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contrast during MRI scans, are developed to improve the MRI image quality, reduce
scan time and lower clinical cost. These agents are paramagnetic entities utilizing
unpaired electrons to alter either the longitudinal (T1) or transverse (T2) relaxation
times of water molecules within their effective sphere of action. Current commercial
agents rely on the 7 unpaired electrons in the f-orbitals of gadolinium (Gd) to relax
the protons of rapidly exchanging coordinated water molecules. It is estimated that
40-50% of the annual 30 million MRI scans utilize a gadolinium chelate to enhance
contrast [6]. Other paramagnetic species, such as Mn(II) and iron oxides, are also
under development [7].
The major disadvantages of these contrast agents are their high dosage necessary
to perform a procedure, and, the weak relationship between pathological changes
and enhanced contrast. Gadolinium-based agents generally require several grams
of compound to be administered intravenously before a MRI procedure [8]. The
toxicity of such large amounts of metal chelates made it not viable for patients with
defective kidney function (Figure 1.1). More importantly, these agents enhance
image contrast without specificity. Due to hydrophobicity of these Gd(III) chelates,
tumors can be distinguished from healthy tissues as a consequence of their high
vascular permeability. However, the confidence level of a bright or dark spot on
MR images being a tumor is disappointingly low [9]. Besides, the requirement for
high Gd concentrations makes it impossible to detect low concentrations of aberrant
proteins or other molecular biomarkers [10].
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1.1.4 Targeted MRI Contrast Agents (Biosensors)
Unlike general contrast agents, targeted imaging agents, also known as biosensors,
aim at specific biological events such as elevated enzyme activity or cell surface
receptor over-expression. In other words, such biosensors generate enhanced image
contrast for specific targets of interest.
To achieve this, Gd(III) chelates and other supermolecular structures with bio-
responsive moieties (e.g. enzyme inhibitors) have been developed [7, 9, 11–14]. Af-
ter delivery and diffusion, these agents are selectively localized around the pres-
ence of targeted biomarkers, thereby generating elevated image contrast for certain
biomarkers. While this specificity may limit their general applicability and market
size, a targeted agent requires much smaller doses than general contrast agents, to
achieve comparable contrast enhancement in regions of interest. Additionally, the
identification and quantification of biomarkers provide much richer molecular in-
formation across different stages of diseases, particularly important for early-stage
cancer detection.
1.2 129Xe in Magnetic Resonance
1.2.1 129Xe and Hyperpolarization
In addition to proton (1H), other nuclei are also viable for MRI. A promising candi-
date for the development of MRI molecular imaging is hyperpolarized 129Xe. This
6
isotope has a 26.5% abundance in Xe gas produced originally from liquid air, which
is highly available. 129Xe has 1/2 nuclear spin, which gives a simple two-level energy
layout that greatly simplifies NMR spectra. 129Xe nuclei present a gyromagnetic
ratio of 11.78 MHz · T−1 [15]; when applied at 1.5 T (a typical field strength for a
clinical MRI scanner), it resonates at 17.7 MHz. Due to its large electron cloud of 54
electrons, mono-atomic 129Xe has a 300 ppm chemical shift window in solvated and
supermolecular forms; while it gives 5000 ppm chemical shift when transformed into
solid state and covalently-bonded compounds. This large spectral range of xenon
resonances has allowed multiple xenon species to be resolved in the frequency do-
main simultaneously. Though non-polar as an atom, the large, polarizable electron
cloud provides a good water solubility of 5 mM under standard conditions, and
it also allows Xe to interact with host molecules and proteins through dispersion
forces [16, 17].
Given all these virtues, the reason that 129Xe stands out from other nuclei is
that it can be readily hyperpolarized, a feature also found in 3He, 13C, and a few
other nuclei. Hyperpolarization is the nuclear spin polarization of a material far be-
yond thermal equilibrium conditions. This non-equilibrium spin distribution allows
for large (104 − 105 fold) but one-time enhancement in NMR signal intensity. This
significant but temporary increase has allowed for the 129Xe NMR study of surfaces,
zeolites, liquid crystalline phases, protein cavities, and, combustion [16,18]. Xenon
is most efficiently hyperpolarized through a process known as spin exchange optical
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pumping (SEOP), which will be discussed in the next chapter. Without quadrupo-
lar and covalent-bonding contributions to relaxation (Xe is a noble gas), 129Xe is
capable of exhibiting long lifetimes in the excited nuclear state (80-120 s T1 when
dissolved in aqueous solutions, and 4 h in natural isotopic abundance xenon ice at
77 K and 5000 G magnetic field), compared to other nuclei.
1.2.2 Developments Underway in 129Xe MRI
As an additional channel of MRI, 129Xe inherits most of the benefits of proton MRI
while providing several extra features. As an exogenous MRI probe, 129Xe enjoys
zero background contrast, which is not possible with proton MRI. Unlike many other
probes and contrast agents, xenon is minimally toxic, due to its inert chemical prop-
erties. In vivo 129Xe MRI has been successfully applied to human lungs and mouse
brains, and demonstrated high spatial resolution, high contrast, and minimal toxic-
ity [19,20]. In future clinical settings, 129Xe images can be acquired simultaneously
with proton images, and two images can be overlaid for analysis. This powerful
technique provides complementary information of fine anatomical structures from
proton and encoded chemical environments from xenon (Figure 1.3).
Targeted contrast agents (biosensors) for 129Xe MRI are under development in
our laboratory [12,21–26] and elsewhere [27–30]. Biosensors have been synthesized
and characterized for various biological events, including pH change [31], zinc con-
centration [32], enzyme activity [21], membrane fluidity [33], and over-expressed
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proteins in cancer cells [22, 26] (Figure 1.2). Some of them demonstrated good cell
uptake [25, 26, 29, 34]. With the wide chemical shift window described in the pre-
vious section, multiplexed imaging with different biosensors targeting orthogonal
biomarkers is viable. For example, enzyme activity sensors when combined with
pH sensing, can provide higher confidence for some diagnostic applications.
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Figure 1.1: Gd(III)-based MRI contrast agents commonly employed in clinics.
Figure from reference [35].
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Figure 1.2: Crystal structure showing a Xe biosensor binding with carbonic anhy-
drase, from reference [22]. The Xe atom (green) is shown with a van der Waals
diameter of 4.3 A˚, the Zn2+ ion is gray, the CAII backbone and surface are tan,
and the MoMo enantiomer of C8B is shown in black (carbon), red (oxygen), and
blue (nitrogen), surrounded by its van der Waals surface (dots). C8B binds in the
active site with the sulfonamidate anion coordinated to Zn2+.
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Figure 1.3: Multi-channel MRI images of a mouse brain with stroke, from reference
[20]. a) Proton apparent diffusion coefficient (ADC) map image. The ischemic
core (stroke center) is indicated by low ADC values (circled by a blue line). (b)
Corresponding hyperpolarized 129Xe chemical shift image (CSI). There is a large
signal void in the ipsilesional (right) hemisphere. The regions of interest (ROIs)
are labeled as follows: ROI1, core; ROI2, normal tissue. (c) Corresponding stained
brain section of the same animal. (d) Tricolor map based on the above images.
Green, red and blue represent nonischemic tissue, core and penumbra, respectively.
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Chapter 2
Hyperpolarized (HP) 129Xe NMR
and Hyper-CEST
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2.1 129Xe Hyperpolarization Through Optical Pump-
ing
2.1.1 Nuclear Spin Polarization (Hyperpolarization)
Hyperpolarization is the nuclear spin polarization of a material far beyond thermal
equilibrium conditions. The term “hyperpolarization” is invented to distinguish
from “polarization” which conventionally relates to the electron cloud density re-
distribution due to surrounding electric fields. The prefix “hyper-” has two-fold
implications: (1) like the term “hyperfine interaction” in molecular spectroscopy, it
indicates the contribution of nuclear spin quantum number to atomic energy levels;
(2) it involves significantly non-equilibrium population distributions of nuclear spin.
Hyperpolarization methods are commonly applied to nuclei such as 13C, 129Xe,
and 3He, where the polarization levels can be enhanced by a factor of 104 − 105
above thermal equilibrium levels (see Figure 2.1). Various hyperpolarization tech-
niques have been developed, including dynamic nuclear polarization (DNP) [36],
spin-exchange optical pumping (SEOP) [37], and PASADENA (para-hydrogen and
synthesis allow dramatically enhanced net alignment) [38]. Our method of choice
is SEOP, which is highly efficient for 129Xe.
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2.1.2 Spin Transfer From Photons to 129Xe Nuclei
The principle of spin exchange optical pumping(SEOP) for noble gas hyperpolar-
ization was originally developed by Bouchiat and coworkers in the 1950s [39]. For
SEOP we assume conditions of high gas pressures. The alkali-metal Rb is embedded
in a high pressure gas mixture (64 psi, 4.3 atm) composed of 89% helium for buffer-
ing, 10% nitrogen for quenching, and 1% natural abundance xenon. In some cases
a slightly higher percentage of xenon is employed. The high gas pressure consid-
erably broadens the optical transitions of the alkali metal atoms, which makes the
efficient use of broadband pumping lasers possible. In practice, broadband, high-
power semiconductor lasers with typically 50 W of laser power are used, and their
line width is 1-3 nm around the center. The N2-quenching gas collisions prevent
depolarization of the alkali-metal atoms caused by radiation trapping processes.
Figure 2.2 shows a simplified picture of the mechanism involved in the two steps of
polarization transfer: (1) the optical pumping process to polarize the Rb electron;
(2) spin exchange between the Rb electron and the Xe nucleus.
Optical Pumping
In the optical pumping process, the photon spin (sz = 1) of a circularly polarized
laser beam (σ+, uniform spin I = 1) is absorbed by a Rb atom. The frequency of
the circularly polarized laser light is tuned to the D1 transition of the Rb atoms
(794.8 nm). Circularly polarized light is generated by passing the laser through a
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beam expander and a λ/4 wave plate (Figure 2.3).
The selective optical transition from the 5S1/2 ground state to the
5P1/2 (J =
1/2,mJ = +1/2) excited state depopulates only the mS = −1/2 ground state with
an optical pumping rate (Figure 2.2), because for right-handed circularly polarized
light (sz = +1), no transition is allowed from the mS = +1/2 ground state to the
two excited states mJ = +1/2 or mJ = −1/2. This follows from the conservation of
angular momentum (selection rule), where the absorption of the circularly polarized
photon spin (sz = +1) only changes the orbital angular momentum (∆L = +1)
of the Rb atom but cannot affect the intrinsic electron spin orientation (∆S =
0). After the mJ = +1/2 excited state is selectively populated with the rate R,
frequent collisions with 4He atoms mix the excited 5P1/2 state into an incoherent
superposition of mJ = +1/2 and mJ = −1/2 states. Therefore the electron spin
order of the excited state is completely destroyed.
The collisional rate for these J-randomizing 4He collisions at 10 bar gas pressure
is 1/TJ ≈ 1× 1011 s−1. Therefore, during an average of every 10 ps, one 4He
atom collides with the excited Rb atom [37]. The J-randomization leads to an
equal population of the two excited states. Subsequent quenching collisions with
N2 molecules transport the excited state non-radiatively to the ground state. The
quenching collisional rate for typical N2 pressures of 0.1-1 bar is about 1/TQ ≈
1× 109 s−1. This corresponds to an average lifetime of <1 ns which is much shorter
than the natural excited state life time of about 30 ns. Therefore, only a small
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fraction of the excited Rb atoms (∼ 1%) can decay radiatively through emission
of a fluorescence photon. The repopulation and depopulation pumping produces
a ground state electron spin polarization, which is destroyed through collisions
with Xe, N2 or He atoms. An important consequence for spin exchange optical
pumping under high pressure conditions is that the passage through the excited
state, (depopulation pumping, J-randomizing and N2 quenching collisions) and most
of the spin polarization destroying relaxation processes are short-lived with respect
to the nuclear spin.
Spin Exchange
The second part of Figure 2.2 shows the transfer of spin polarization from the Rb-
electron spin to the nuclear spin of the Xe atom. Under high pressure conditions,
there are mainly binary collisions between Rb and Xe atoms in the gas phase, which
leads to short-lived Rb-Xe complexes. The Rb-electron spin of the transient Rb-
Xe complex has a non-zero probability of being at the position of the Xe-nuclear
spin. This is the physical origin for the isotropic hyperfine coupling, also called
Fermi contact interaction. The form of the coupling indicates that the transfer is
mediated by flip-flop processes between the Rb-electron spin and the Xe-nuclear
spin. When the gas pressure is low, the main contribution for the polarization
transfer comes from long-lived van der Waals complexes. This phenomenon was
intensively studied by Happer et al. [40].
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As the electronic and nuclear spins are polarized on a much longer timescale
than photon absorption, J-randomization, and collision quenching, the steady-state
approximation for spin populations leads to a simplified description of the spin
exchange optical pumping process, which features a “spin temperature” parameter.
After the Rb valence electron is spin polarized and aligned with the outer magnetic
field, it displays a low “spin temperature” and serves as a “cold” spin reservoir. Xe
nuclei are in close contact with this reservoir and their spin temperature is “cooled
down” (see Figure 2.2), thereby achieving xenon nuclear spin polarization. This
process can be operated under continuous xenon gas flow (Figure 2.3).
2.1.3 Cryogenic Separation of Pure HP Xe
Given enough laser power to maintain the Rb electron polarization, the gas mixture
(N2, He, Xe) can be flowed through the optical pumping glass cell continuously
(Figure 2.3). To utilize this feature and attain large quantities of pure HP Xe, a
cryogenic separation technique has been developed [41,42]. As the gas stream (N2,
He, Rb vapor, HP Xe) flows out of the optical pumping chamber, the Rb vapor
condenses on the inner surface of the tubing and other inert gases (containing HP
Xe) are passed through. Further down the gas line a cold finger at 77 K traps Xe
as a solid and accumulates Xe as “ice” (melting point 161.25 K) during the time of
operation. Other gas components flow out of the setup exhaust. 129Xe retains its
polarization during freezing [41] and the relaxation time of solid 129Xe is about 3 h
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at 77 K [43]. The spin lattice relaxation time T1 of the solid-phase
129Xe constrains
the duration of the accumulation to be within a few hours. After an accumulation
time ta (typically 20-40 min in practice), the remaining polarization of the
129Xe
ice is:
PXe(ta) = PXe(0)(T1/ta)(1− e−ta/T1) (2.1.1)
where PXe(0) is the polarization of the
129Xe exiting the optical pumping cham-
ber [42]. The final polarization of the 129Xe gas for a desired volume can be max-
imized by appropriate choice of gas flow rate and accumulation time. After accu-
mulating sufficient hyperpolarized 129Xe ice, the gas line is closed and evacuated to
less than 5 Pa. Then HP Xe gas is released by quickly warming the xenon ice, and
sealed in a NMR tube with liquid sample. The measured final polarization level is
10-15% at a volume of 0.1 L.
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2.2 Hyperpolarized 129Xe Chemical Exchange Sat-
uration Transfer (Hyper-CEST) NMR
2.2.1 Chemical Exchange Saturation Transfer (CEST) in
Proton MRI
As discussed in the introduction, the new landscape of molecular imaging applica-
tions prompts the search for new paradigms in the design of MRI contrast agents.
A general insight deals with the exploitation of frequency, the key parameter of the
NMR phenomenon. The possibility of designing frequency-encoded MRI protocols
based on controlled magnetization transfer appears a very interesting perspective
in terms of sensitivity enhancement. In the last decade, there has been a surge in
NMR exchange applications due to the utilization of the highly controllable sat-
uration transfer, which can be combined with proton exchanges between different
chemical environments.
The first to demonstrate that exchange between labile protons of low-concentration
solutes and water protons provides a sensitivity enhancement scheme were Balaban
et al., who named this new MRI contrast mechanism chemical exchange depen-
dent saturation transfer (CEST) [44]. In their experiments, barbituric acid and
5,6-dihydrouracil, both conducting proton exchanges with water, were selected as
the sites for RF pulse saturation (see Figure 2.4). During CEST experiments, the
proton spins in these compounds got saturated in a frequency-specific way by radio
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frequency (RF) irradiation. As a result, spin population inversion in the selected
frequency is transferred into the pool of water protons, through chemical exchange
processes that are faster than spin relaxation. This process leads to a reduction of
water proton signal intensity. Reporting the molecular information associated in-
directly with the exchanging species, readouts of CEST experiments are the water
signal intensities at different saturation frequencies and RF pulse strengths used.
As the water signal is usually much stronger than any other proton species under
observation, measuring the signal reduction instead of directly measuring the target
proton species provides as much as 500,000-fold sensitivity enhancement [45].
The theoretical aspect of CEST generally aims at the description and quantifi-
cation of the effects, and design and optimization of experimental schemes. For a
spin system without scalar couplings, chemical exchange processes are commonly
described by modified Bloch equations including exchange terms, sometimes called
the Bloch-McConnell equations [46]. It is difficult to obtain the exact analytical
solutions of these equations, even for the case of two-site exchange. Therefore, most
investigators endeavor to derive concise analytical solutions of the problem using
some reasonable assumptions.
2.2.2 Hyper-CEST with 129Xe
CEST can also be applied to HP 129Xe to observe chemical exchange sites indirectly,
producing the acronym “Hyper-CEST”. With HP 129Xe, Hyper-CEST solves both
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the contrast and the intensity problem for MRI. In Figure 2.5, a typical spectrum
of 129Xe biosensor is shown. Due to the low concentration of biosensors (∼100
µM), and the high concentration of dissolved 129Xe (∼15 mM); the biosensor signal,
which is also used in imaging, is 1000 times weaker. In direct detection, most Xe
atoms are not contributing to the final imaging contrast, and the biosensor signal
is not strong enough for more demanding applications. With Hyper-CEST, the
biosensor signal can be analyzed indirectly via generating and observing changes in
the Xe(solvent) signal, through saturation transfer mediated by chemical exchange.
By tuning the saturation frequency, very clear signal contrast for identification of
the biosensor can be generated at picomolar concentration, which will be shown in
the following chapters.
2.2.3 Hyper-CEST Radio-frequency Pulse Sequence
In a NMR experiment, selective saturation is accomplished by radio-frequency (RF)
pulses. A pulse sequence used in most Hyper-CEST experiments is shown in Figure
2.6. Multiple (L6) selective saturation 180◦ RF pulses (sp6) were irradiated at
the Xe@host resonance frequency; meanwhile, HP Xe and depolarized Xe were
dynamically exchanging with the host sites. Time-delay parameters (d1, d12) in the
pulse sequence are used for coordinating the saturation cycle into the Xe exchange
time frame. As a result, overall Xe depolarization was accumulated in the aqueous
sample, and detected by another 90◦ hard excitation pulse (p1). Without Hyper-
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CEST, HP Xe goes through depolarization exponentially by a time constant close to
the Xe relaxation constant T1 (∼70 s when Xe is dissolved in water). For contrast,
in the Hyper-CEST experiments with “depolarization catalyst” and “on-resonance”
saturation transfer, the depolarization rates were observed to be much faster.
2.2.4 HP Xe Gas Delivery Control Device
To describe a biosensor’s Hyper-CEST behaviors at different saturation frequencies
and/or saturation powers, a series of Hyper-CEST data with a consistent Xe signal
intensity are required, for comparison in the exchange experiments. However, due
to the evanescent nature of 129Xe hyperpolarization and the fast-changing hyperpo-
larization level, this has been impossible for batch-mode Xe delivery setups. On the
other hand, for most continuous-flow gas delivery setups, turbulence and bubbles
will affect magnetic field homogeneity in NMR samples.
These issues are solved by a home-built semi-continuous flow delivery setup for
HP Xe (Figure 2.7). Freshly hyperpolarized gas mixture (89% helium, 10% nitrogen,
and 1% natural abundance xenon), with a pressure of 66.7 psi, was guided from the
hyperpolarizer to the NMR tube. The gas mixture was bubbled through the liquid
sample by a capillary dispenser and the exhaust is guided to air. The flow rate
is controlled by a pinch valve near the exhaust. After 20 seconds of bubbling, gas
flow is stopped by two solenoid valves, controlled by a programmable relay from
the computer. Immediately after flow is stopped, the Hyper-CEST pulse sequence
23
is started and NMR data are acquired. By the time acquisition is finished, gas flow
is started again and fresh Xe is replenished through bubbling. With these steps
repeated, Hyper-CEST experiments can be done with a near-constant starting Xe
signal intensity.
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Figure 2.1: Comparison between thermally polarized and hyperpolarized NMR
spectra. The population distributions on the spin energy levels are exaggerated
for clarity. The signal/noise ratio for the hyperpolarized sample is 104-fold higher
compared to the thermally polarized sample, given the same radio-frequency exci-
tation.
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Figure 2.2: Two-step spin transfer in Spin-Exchange Optical Pumping (SEOP).
First, spin angular momentum is accumulated in Rb valence electrons. In the
following step, Xe nuclei achieve hyperpolarization through collision and hyperfine
interaction.
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Figure 2.3: Spin-Exchange Optical Pumping (SEOP) setup. Spin angular momen-
tum is transferred from circularly polarized photons (spin I = 1, 100%) to Xe nuclei
through excited Rb. Nitrogen gas is used to quench exited state Rb quickly to
facilitate spin transfer.
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Figure 2.4: Temperature-dependent CEST spectra of barbituric acid solution (62.5
mM, 20 mM phosphate buffer), pH 7.4, from reference [44].
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Figure 2.5: Directly detected 129Xe spectrum of triacetic acid cryptophane-A deriva-
tive (TAAC). Xe dissolved in water appears at 194 ppm. Inset zooms in at the
Xe@TAAC signal at 68.1 ppm.
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Figure 2.6: Hyper-CEST pulse sequence diagram, with parameters provided for
in-house 10 mm PABBO probe. Different values were chosen considering biosensor
concentration, sample temperature, HP Xe flow rate. Based on a recent saturation
transfer optimization study [47], saturation pulse is DSnob-shaped to enhance power
efficiency.
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Figure 2.7: HP Xe gas mixture continuous-flow delivery setup. Typically the flow
rate ranges between 0.6 and 0.8 standard liters per minute (SLM). The sample
solution is saturated by HP 129Xe after continuously running the gas line for 20 s,
which is confirmed by monitoring 129Xe signal intensity using small flip-angle pulses.
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Chapter 3
HP 129Xe NMR of Various
Cryptophane-A Derivatives
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3.1 Cryptophanes as Effective Xe Binders
Due to its small size (r = 2.17 A˚), lipophilic character, and polarizability, Xe is
capable of crossing cell membranes, and has been detected in hydrophobic pock-
ets of proteins [48–51]. Xenon is also known to bind to a variety of synthetic
host molecules with hydrophobic cores such as α-cyclodextrin [52], cucurbituril
[53], hemi-carcerands [54], and a large portion of the cryptophane family [55].
Cryptophane-A and its variants have been the subject of more xenon binding stud-
ies than any other synthetic molecule. As shown in Figure 3.1, cryptophane-A
is composed of two cyclo-triveratrylene (CTV) caps linked by three dioxyethylene
bridges, thereby enclosing a void space in the center. Cryptophane-A is chiral with
a D3 axis of symmetry. For further applications in this report, only the anti isomer
is used for biosensors [55], as the corresponding syn isomer (with a mirror plane
and C3 symmetry axis) is not formed under most synthetic conditions. Some of the
best known Xe binders (Figure 3.2) [24, 56] are derived from cryptophane-A, and
biosensors exploiting these properties have been synthesized by attaching different
targeting/sensing moieties to these cryptophanes.
3.1.1 Water-soluble Cryptophanes
As cryptophane-A is intrinsically hydrophobic, members of the Dmochowski lab-
oratory have worked to increase its water solubility by substituting the methyl
groups in one of the two CTV caps, with acetic acid, triazole-propionic acid, and
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triazole-ethylamine groups (see Figure 3.2). The tris-amine cryptophane currently
has the highest affinity of known Xe host molecules at room temperature in aqueous
solution, which is shown in table 3.1 [24,56].
Table 3.1: Xe binding affinities for water-soluble cryptophanes. Described as
binding constant (KA) and dissociation constant (KD)
Cryptophane derivatives KA KD
Tris(acetic acid) cryptophane (TAAC) 33 000 ± 2000 M−1 30 ± 2 µM
Tris(triazole ethylamine) cryptophane
(TTEC)
42 000 ± 2000 M−1 24 ± 1 µM
Tris(triazole propionic acid) cryptophane
(TTPC)
17 000 ± 2000 M−1 58 ± 7 µM
3.1.2 Tri-propargyl Cryptophane and Click-reaction
To facilitate the attachment of functional moieties to cryptophanes, a template
cryptophane named tri-propargyl cryptophane was previously synthesized by Aru
Hill in our lab (see Figure 3.2, details can be found in reference [57]). In this cryp-
tophane, all methyl groups on one cap of cryptophane-A are replaced by propargyl
groups, which allows the well-used [3+2] cyclo-addition “click reaction” [58]. In
the following sections, biosensors derived from this template cryptophane and their
129Xe NMR behaviors will be discussed.
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3.2 Carbonic Anhydrase Biosensors
3.2.1 Introduction
Human carbonic anhydrase (CA) is involved in many physiological processes such
as carbon dioxide transport and pH homeostasis in tissue [59]. However, some CAs
also appear to have detrimental effects on human health: For example, CA I, II, and
other isozymes were shown to be present and probably involved in the formation
of certain tumors and polycystic kidney disease [60, 61]. Particularly, upregulated
CA IX and XII levels are found in various human cancer cells and can be used as a
biomarker for cancer diagnosis [62, 63]. Thus, the development of isozyme-specific
CA biosensors holds considerable promise for cancer imaging. Numerous crystal
structures of CA-inhibitor complexes are available to guide biosensor development,
and CA II in particular has served as a successful model system for rational drug
design [64–66].
In previous works from our lab [22, 67, 68], xenon biosensors targeting CA were
synthesized and characterized. The strategy for constructing protein-targeted xenon
biosensors is to covalently attach a targeting ligand to the cryptophane. Through
protein-specific binding of biosensors to proteins, the cryptophane-associated Xe
atom experiences a different magnetic environment that depends on whether the
encapsulating biosensor is bound to protein, and what kind of protein is bound to
the biosensor. In several published studies, CA has been viewed as a model system
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for understanding protein-ligand interactions [64].
3.2.2 Distance Variations
129Xe NMR studies of peptido-biotin cryptophane biosensors have shown that de-
creasing the linker length to the biotin ligand increases the NMR signal change
(upon avidin binding) in chemical shift as well as the line width [28]. To further
study the effect of linker length on the 129Xe NMR signals, biosensors for CA were
developed by attaching azido-benzenesulfonamide of different linker lengths to the
tri-propargyl cryptophane, through [3+2] cyclo-addition as discussed in the previ-
ous section. More, to increase the biosensors’ water solubility, and to avoid the
appendage of additional stereo-centers to the cryptophane core, two propionic acid
groups were also “clicked-on” (see Figure 3.4).
In Figure 3.5, a series of HP 129Xe NMR spectra is shown for biosensors with
different linker length (6-8 bonds) binding to CA I and II. Detailed discussion can be
found in reference [22]. Three important findings can be summarized: (1) biosensors
of different linker lengths display distinguishable chemical shift differences, which
proves though not covalently bonded, Xe can still report its chemical environment
due to its high electron polarizability; (2) multiple “bound” signals for biosensor-
protein complexes were observed, indicating multiple interaction paradigms; (3)
different isozymes of the same protein can be distinguished by 129Xe biosensors.
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3.2.3 Stereochemistry
In a previous study of biotinylated biosensor targeting steptavidin, attaching a pep-
tide to the chiral cryptophane created diastereomers, which increased the number
of peaks in the 129Xe spectrum, and correspondingly decreased the signal-to-noise
ratio. Computational studies have helped to assign the various NMR resonances to
their respective diastereomers [69]. However, the tetrameric nature of avidin can
further complicate the 129Xe NMR spectrum [28].
To investigate whether enantiomers of the same biosensor behave differently in
the biosensor-CA binding event, stereopure C7B biosensor was synthesized in the
Dmochowski lab [68]. HP 129Xe NMR spectra were acquired with different biosen-
sor to protein ratios (see Figure 3.7). Both (+)−C7B and (−)−C7B have the same
NMR signal when “free” in solution. When bound to wild-type CA II, (+)−C7B
shows sharp “bound” peaks indicating relatively less constrained interaction, be-
tween biosensor and protein. On the other hand, (−)−C7B shows broad “bound”
peaks, which is attributed to more rigid interactions between biosensor and pro-
tein and therefore increased the biosensor-protein complex NMR relaxation time.
More, the most down-field shifted “bound” peak, also observed in Figure 3.5, is
only present for (+)−C7B. These interesting phenomenon confirmed part of our
hypothesis that the two enantiomers behave differently in 129Xe NMR; however,
the origin of the two “bound” peaks was not deconvolved.
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3.2.4 Binding Sites
Further efforts were made to resolve the origin of the two “bound” peaks for
biosensor-CA II complexes (see Figure 3.5). It has been shown that CA II con-
tains two binding sites for the sulfonamide group, one near the enzyme active site
and the other close to the enzyme active site entrance [59]. Mutants of CA II were
made by changing single amino acids near each of the two sites. D19L and H94R
mutants were designed and prepared by our collaborators from the Christianson
group. These mutations aimed at geometrically blocking the entrance of sulfon-
amide groups from entering the binding sites, and unpublished protein structures
from crystal structures have proved their validity. Upon binding to C8B at a 1:1
ratio, each of the mutants presents only one “bound” signal on the 129Xe NMR
spectra. These results agree well with previous studies with the wild-type CA II
(Figure 3.5), which proves the two-site model can be applied for assigning 129Xe
NMR signal of biosensor-protein complexes.
In summary, with the advancement of HP 129Xe NMR techniques, higher reso-
lution NMR spectra for biosensor-protein bound complexes can be acquired, which
provides the opportunity to further understand the biosensor targeting interaction.
Linker lengths, stereochemistry, and binding-site alterations all contributed in the
variations of 129Xe NMR signals. With the study of the CA-biosensor model sys-
tem, molecular information can be acquired in possible MRI studies that utilize the
highly sensitive 129Xe chemical shift changes.
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3.3 Integrin Biosensor
Peptide-modified cryptophane enables sensitive detection of protein biomarkers us-
ing HP 129Xe NMR spectroscopy. As αvβ3 integrin receptor is overexpressed in
many human cancers, it can serve as a potential biomarker for HP 129Xe MRI.
Targeting and delivery of cryptophane to cells expressing αvβ3 integrin receptor
has been achieved [26]. In the previous work, cryptophane was functionalized with
cyclic RGDyK peptide and Alexa Fluor 488 dye, and cellular internalization was
monitored by confocal laser scanning microscopy. The peptide-cryptophane con-
jugate was determined to be nontoxic in normal human lung fibroblasts by MTT
assay at micromolar concentrations (typical for hyperpolarized 129Xe NMR biosens-
ing experiments). Flow cytometry revealed 4-fold higher cellular internalization in
cancer cells overexpressing integrin receptor compared to normal cells. Nanomo-
lar inhibitory concentrations (IC50 = 20-30 nM) were measured for cryptophane
biosensor against vitronectin binding to αvβ3 integrin and fibrinogen binding to
αIIbβ3 integrin.
To test the biosensor’s viability for HP 129Xe MRI, NMR spectra for various
supermolecular complexes are acquired. In Figure 3.10(b), biosensor (50 µM) and
αIIbβ3 integrin (16 µM) were mixed in Tris buffer (1 mM, pH 7.2) with 30% glycerol
and 0.1% Triton X-100. The αIIbβ3 integrin was chosen instead of αvβ3 integrin, due
to the relative ease of isolating and lower cost of purchasing milligram quantities
of this protein. Keeping the αIIbβ3 integrin membrane protein in buffer solution
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required addition of glycerol and Triton X-100, and glycerol also mitigated foam-
ing while introducing Xe. “Free” cryptophane gave a 129Xe NMR peak at 67.1
ppm, while “bound” cryptophane appeared at 71.2 ppm, representing a 4.1 ppm
down-field shift (see Figure 3.10(b)). Signal-to-noise ratio for the single “bound”
cryptophane-protein peak was ∼3:1. With the racemic mixture of biosensors, pro-
tein binding results in diastereomers, which in some cases can produce multiple
“bound” 129Xe NMR peaks [22,69]. We have seen single “bound” peaks previously
in cases where the cryptophane enantiomers are constrained near the protein target
surface, and the xenon by chance senses the environment identically. The short
alkyl spacer (between the triazole and c[RGDyK] peptide in the integrin biosen-
sor) may similarly constrain both cryptophane biosensor racemates at the integrin
receptor, creating effectively one xenon binding site. Alternatively, a second peak
corresponding to the other diastereomer may reside under the “free” peak (∼67
ppm).
This 4.1 ppm change in chemical shift is comparable to our previous carbonic
anhydrase biosensor work (3.0-7.5 ppm) [22] and a biosensor optimization study
with biotin-avidin (3-4 ppm) [70]. Considerably smaller 129Xe NMR chemical shifts
were observed in two related protein-binding studies (biotin-avidin, ∼1 ppm [27];
major histocompatibility complex, ∼1 ppm [71]). To make a competition assay
(Figure 3.10(c)), c[RGDyK] (100 µM) was added to a fresh solution (1 mM Tris
buffer, pH 7.2; 30% glycerol and 0.1% Triton X) containing biosensor (100 µM)
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and αIIbβ3 integrin (20 µM). Here “free” cryptophane gave the same
129Xe NMR
chemical shift, and no “bound” cryptophane was detected, which indicated that the
peptide blocked biosensor from binding to αIIbβ3 integrin. The disappearance of the
smaller “bound” peak after addition of the competing peptide further confirmed
that the spectral change observed upon addition of αIIbβ3 is due to protein binding
by the cryptophane biosensor.
3.4 pH Sensor
A recent study by lab coworker Brittany Riggle focuses on developing a pH biosen-
sor based on the tri-propargyl cryptophane. pH variation is often found in the
extracellular environment of tumor cells, and various tumors are demonstrated to
acidify their micro-environment to levels between 6.2-6.9 from pH levels of 7.3-7.4,
so as to facilitate cancer metabolism and metastasis [72,73]. Multiple attempts have
been made to monitor extracellular pH using MRI contrast agents [74–78]. This
work aims at generating a pH-biosensor relevant to in vivo pH ranges, and the syn-
thetically derived EALA peptide was selected. EALA peptide is a 30-mer peptide
made up mostly of glutamic acid, alanine, leucine, alanine repeats; in reaction to
a reduction in pH from 7 to 5, it undergoes a conformational change from random
coil to α-helix [79]. The amphipathic α-helix binds bilayer membranes; the nature
of such interactions are dependent on the physiological environment and the chem-
ical make-up of the membrane but this feature may prove to have interesting uses
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in biological studies [80]. After adding an azide group, the peptide was attached
to the tri-propargyl cryptophane by [3+2] azide-alkyne cycloaddition. Additional
propionic acid was also attached to the cryptophane by the same method 3.11.
To show the sensitivity of 129Xe NMR chemical shift in response to pH change,
two physiologically relevant pH values (7.5, 6.5) were selected to measure the chem-
ical shift changes on 129Xe NMR. At pH 7.5, only one peak was shown, as the at-
tached EALA peptide was in 100% disordered state. When buffer pH was changed
to 6.5, an additional peak was also observed, which indicate the peptide underwent
partial change into α-helix 3.12, and both the disordered and alpha-helical confor-
mations were present in solution. This proves even though Xe is encapsulated inside
a cryptophane, it can still respond to different isomers of large proteins shown in
the last example, as well as a small peptide conformational change.
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Figure 3.1: Structure of cryptophane-A. Cryptophane-A consists of two cyclotriver-
atrylene (CTV) caps joined by ethylene ether bridges. The near-spherical molecule
has a diameter of 1 nm and an internal volume of approximately 95 A˚3.
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Figure 3.2: Structure of tris(triazole propionic acid) cryptophane (TTPC),
tris(acetic acid) cryptophane-A (TAAC), tris(acetic acid) cryptophane (TTPC),
tris-(triazole ethylamine) cryptophane (TTEC), and tri-propargyl cryptophane
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Figure 3.3: Crystal structure of Xe bound to tripropargyl cryptophane-A
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Figure 3.4: Structure of trifunctionalized cryptophane biosensors C6B, C7B, C8B,
for targeting carbonic anhydrase, from reference [22].
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Figure 3.5: HP 129Xe NMR spectra of benzenesulfonamide biosensors binding to
wild-type carbonic anhydrase isomers I and II, from reference [22]. (a,d,g) 129Xe
NMR spectra showing individual biosensors free in solution, (b,e,h) 129Xe NMR
spectra showing each biosensor bound to CAI. (c,f,i) 129Xe NMR spectra showing
each biosensor bound to CAII. (a) C6B alone (96 µM); (b) C6B (188 µM) and CAI
(141 µM); (c) C6B (148 µM) and CAII (123 µM); (d) C7B alone (186 µM); (e) C7B
(136 µM) and CAI (100 µM); (f) C7B (132 µM) and CAII (105 µM); (g) C8B alone
(121 µM); (h) C8B (189 µM) and CAI (141 µM); (i) C8B (189 µM) and CAII (153
µM).
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Figure 3.6: Structure of stereo-pure tri-substituted cryptophane-A derivatives, from
reference [68]. By attaching mosher’s acid moieties and column chromatography
separation, two enantiomers of cryptophanes can be separated, and further substi-
tuted into other tri-functionalized cryptophanes. Note the difference between (2a)
and (2b) is the orientation of linkers between two caps.
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Figure 3.7: HP 129Xe NMR spectra of stereo-pure C7B carbonic anhydrase biosensor
binding to wild-type carbonic anhydrase II.
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Figure 3.8: HP 129Xe NMR spectra of C8B carbonic anhydrase biosensor binding
to H94R and D19L mutants of carbonic anhydrase II.
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Figure 3.9: Structure of αvβ3 integrin biosensor. The cyclic RGDyk peptide moiety
serves to target the integrin.
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Figure 3.10: HP 129Xe NMR spectra of αvβ3 integrin biosensor. (a) biosensor
dissolved in Tris buffer (1 mM, pH 7.2) gave 129Xe NMR chemical shift at 65.8
ppm. (b) biosensor and αIIbβ3 integrin were mixed in Tris buffer with 30% glycerol
and 0.1% Triton X-100. “Free” cryptophane gave 129Xe NMR chemical shift at
67.1 ppm, while “bound” cryptophane appeared at 71.2 ppm, representing a 4.1
ppm down-field shift. (c) c[RGDyK] displaced biosensor from αIIbβ3 integrin, in
same buffer as (b). “Free” cryptophane gave the same 129Xe NMR chemical shift,
however no “bound” cryptophane was detected.
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Figure 3.11: Structure of pH-sensitive cryptophane derived from EALA peptide.
This cryptophane is derived from tri-propargyl cryptophane-A. EALA peptide and
two propionic acid moieties are covalently bonded by click-chemistry. Conforma-
tional changes in the peptide at different pH values result in different 129Xe NMR
spectra.
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Figure 3.12: HP 129Xe NMR spectra of EALA cryptophane at different pH. At
pH 7.5 only one signal (66.3 ppm) of Xe@crypt exists, showing uniformly random
peptide conformation; At pH 6.5 another signal (68.9 ppm) appears, indicating the
peptide partially forms α-helix.
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Chapter 4
Ultrasensitive Hyper-CEST NMR
with TAAC
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4.1 Background
Methods for detecting trace analytes play critical roles in chemistry and many ap-
plied fields, including biotechnology, biophysics, molecular pathology, metallurgy
and homeland security. Nuclear magnetic resonance (NMR) spectroscopy is a ver-
satile technique for probing molecular structure but typically offers limited detec-
tion sensitivity, based on the small magnetic moment of commonly employed nuclei
(e.g., 1H, 13C, 15N) and the narrow separation in energy levels between nuclear spin
transitions. This leads to small polarization of the nuclear spin reservoir, where
the difference in spin populations aligned parallel or anti-parallel to an external
magnetic field at thermal equilibrium is typically just 1 in 1× 105 spins. Thus, sig-
nificantly enhanced NMR signals can be obtained via hyperpolarization techniques
capable of generating a nuclear spin polarization level approaching 100% [37,40].
For applications in biodetection and materials science, we [22] and others [55]
have investigated the noble gas isotope 129Xe, which is spin-1/2 and readily hyper-
polarized (HP) via spin-exchange optical pumping. However, due to low concen-
trations of the delivered magnetic species and short spin relaxation lifetimes, the
signal intensity is still not ideal for many demanding applications, e.g., clinical
MRI [12, 81]. When exchanging magnetic species are present, chemical exchange
saturation transfer (CEST) can provide another source of signal amplification based
on cumulative magnetization transfer through selective saturation [13]. For proton
MRI, CEST contrast originates from exchange of endogenous or exogenous amide
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or hydroxyl protons with bulk water protons, or from exchangeable sites on param-
agnetic inorganic coordination complexes [14, 82]. This gives the possibility of de-
signing extremely sensitive contrast agents that respond to various exchange events,
with techniques known as PARACEST [83] and LIPOCEST [84]. More recently, the
analogous technique involving HP 129Xe CEST (Hyper-CEST) was developed [85].
Based on its considerable polarizability, xenon exhibits significant affinity for or-
ganic host molecules known as cryptophanes [23,24,55,56,86–89]. In one example,
Hyper-CEST was applied to virus capsids modified by ∼125 cryptophanes, thereby
attaining 0.7 pM capsid detection sensitivity [30].
Here we present ultrasensitive Hyper-CEST NMR with a water-soluble triacetic
acid cryptophane-A derivative (TAAC, Figure 4.1). 129Xe NMR biosensors using
similarly derivatized cryptophanes have been shown previously to be useful for de-
tecting a wide variety of analytes [21, 22, 26, 27, 29, 31, 71, 90–92]. This single-unit
cryptophane derivative, TAAC, was indirectly detected at 1.4 picomolar concentra-
tion at 320 K in aqueous solution, which is the record for a xenon host. Thermody-
namic and kinetic studies of xenon binding were carried out to investigate this sen-
sitivity enhancement, which establish TAAC as a very effective xenon binder/“spin
catalyst” under the Hyper-CEST scheme. Our results suggest multiple Xe exchange
processes for cryptophane-mediated HP 129Xe NMR signal enhancement.
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4.2 Experimental
4.2.1 Materials
TAAC was previously prepared by a thirteen-step synthesis [24], and found to be
soluble to ∼500 µM in aqueous solution (pH 7), owing to its three carboxylates.
The identity and purity of TAAC were confirmed by 1H NMR spectroscopy. TAAC
features a xenon association constant (KA) of 33 000 M
−1 at 293 K, making it
currently one of the highest-affinity Xe host molecules [24,56,87].
Ultra-filtered water (18 M · Ω · cm resistivity) obtained from Mar Cor filtra-
tion system, was used to prepare TAAC solutions. TAAC (1.43 mg) was carefully
weighed and dissolved in 10 mL water to form a 140 µM solution, which was con-
firmed by Agilent 8453 UV-vis spectrophotometer (285 cm−1). For the Hyper-CEST
experiments a series of 10-fold dilutions with ultra-filtered water was performed to
bring TAAC solution down to picomolar concentrations. Dilutions were made with
well calibrated Eppendorf Research pipettes with <1% error. After each dilution,
solution was vortexed to homogenize sample. Reagents were used as purchased
from Fisher: sodium phosphate dibasic heptahydrate, sodium phosphate monoba-
sic dihydrate. Prior to isothermal titration calorimetry (ITC) measurement, TAAC
solution was dialyzed in phosphate buffer (20 mM, pH 7.5) by GE Mini Dialysis
Kit (1 kDa cut-off).
In the NMR samples, xenon concentrations were calculated by multiplying the
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xenon partial pressure with its mole-fraction solubility in water, at a given tempera-
ture. For example, during the Hyper-CEST experiment at 320 K (Xe, all isotopes),
is calculated as: xenon partial pressure in gas line × mole fraction solubility (at
320 K, 1 atm) × molarity of water = 0.045× 4.95× 10−5× 55.5 M = 0.12 mM, fol-
lowing Henry’s Law. The concentration of hyperpolarized 129Xe in solution (3.2-4.8
µM) was determined by multiplying [Xe] by the natural isotopic abundance (26.4%)
and the hyperpolarization level (10-15%), measured by comparing with thermal Xe
sample [93].
4.2.2 General NMR Method
A 500 MHz Bruker BioDRX NMR spectrometer was used for all 129Xe NMR mea-
surements. RF pulse frequency for 129Xe was 138.12 MHz. Samples were observed
using either a 5 mm PABBO NMR probe or a similar 10 mm probe. HP 129Xe
was generated using a home-built 129Xe hyperpolarizer, based on the Nycomed-
Amersham (now GE) IGI.Xe.2000 commercial system. A gas mixture of 89% he-
lium, 10% nitrogen, and 1% natural abundance xenon (Concord Gases, NJ) was
used for the hyperpolarizer input. 129Xe was hyperpolarized to 10-15% after optical
pumping of Rb vapor with 795 nm circularly polarized laser, cryogenic separation
of Xe, and accumulation and collection in CAV NMR tubes (New Era). For the
TAAC spectrum and exchange rate measurements, after introducing HP Xe to sam-
ple solution, the sealed NMR tube was shaken vigorously to mix solution with HP
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129Xe.
Directly recorded 129Xe NMR spectra were acquired using 30◦ hard excitation
pulses (7.5 µs on 5 mm probe), or 90◦ EBurp1 shaped pulses (7.5 ms, 602 Hz
excitation bandwidth). Spectra were signal averaged by 10-30 scans. A delay of
0.15 s was given between scans to allow depolarized Xe to leave the cryptophane
cavity and fresh HP Xe to enter the cavity. The spectra shown in Figure 4.2, page
75 were exponentially broadened by 4 Hz to give a larger signal/noise ratio. Sample
temperature was controlled by VT unit on NMR spectrometer to ± 1 K.
At a series of temperatures from 300-325 K, HP 129Xe NMR spectra were ac-
quired following the aforementioned protocol and the natural line widths of the
Xe@TAAC peaks were fitted (FWHM, Lorentzian) and summarized in Table 4.1.
4.2.3 Hyper-CEST Method
Figure 4.3 illustrates the Hyper-CEST experiment involving TAAC. Before starting
the pulse sequence each time, a controllable amount of HP Xe was delivered into
the 3-mL sample solution, and sealed in the NMR tube for signal stabilization by
a homebuilt continuous-flow HP Xe delivery setup (Figure 2.7, page 31). Multi-
ple selective 180◦ radio-frequency (RF) pulses were delivered to the sample at the
129Xe@TAAC resonance frequency, while HP Xe and depolarized Xe were dynami-
cally exchanging in and out of TAAC. As a result, depolarized Xe was accumulated
in the aqueous sample, and detected by another 90 degree hard excitation pulse.
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HP Xe in water undergoes depolarization exponentially by the time constant T1.
However, in the Hyper-CEST experiment TAAC served as a “depolarization cata-
lyst”, and could be turned “on” and “off” using a saturation frequency that was
either on- or off-resonance with 129Xe@TAAC.
Utilizing a home-built continuous flow HP Xe delivery setup (Figure 2.7, page
31), freshly hyperpolarized Xe gas mixture was bubbled through sample solutions
at 65 psi. Before starting the pulse program each time, bubbling was stopped by
two solenoid valves to maintain magnetic field homogeneity.
The Hyper-CEST experiment was carried out using the pulse program illus-
trated in Figure 2.6. DSnob-shaped pulses (parameter sp6) were looped numerous
times (L6) to induce xenon polarization transfer. In the low concentration trials,
where d12  sp6 in duration, the radiation became near-continuous. The DSnob
pulse power was calibrated to give maximum saturation. With a single DSnob
pulse (sp6) irradiated at Xe(aq) frequency, ¿90% signal was saturated. After the
overall polarization was reduced by saturation pulses and chemical exchange, the
sample was irradiated with a 90 degree hard pulse to read out the final magneti-
zation state of 129Xe in solution. Due to imperfection of frequency selectivity, sp6
contributed significantly to the off-resonance regions of the spectrum after 10 000
repeats. Therefore, for the lowest concentration TAAC Hyper-CEST experiments
the Xe(aq) peaks were relaxed faster than the analogous T1 of HP
129Xe in aqueous
solution.
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4.2.4 Isothermal Titration Calorimetry (ITC)
ITC samples were prepared as described, and xenon binding measurements were per-
formed using a MicroCal VP-ITC titration micro-calorimeter (Northampton, MA)
at 310 K. Standard protocols and data analyses were used. Control enthalpograms
for ITC are presented in Figures 4.6, 4.7, 4.8.
Xe@TAAC NMR line widths at different temperatures. The spectra were Lorentzian
deconvolved to fit for full width at half maximum (FWHM). Peak widths of the
Xe@TAAC peaks were corrected by subtracting the Xe(aq) peak line widths to ac-
count for magnet inhomogeneity. The line widths of Xe(aq) peaks range between
8-18 Hz (from 297 K to 320 K), which mainly originates from magnetic field ho-
mogeneity. This response of aqueous 129Xe to temperature change was negligible
compared to 129Xe@TAAC peaks (Table4.1).
Xenon exchange lifetime measurement. Though 2D EXSY NMR is the standard
method for determining exchange rates [94], selective 1D EXSY NMR [28, 95, 96]
serves as a better measurement scheme in this case, due to the spectral dominance
of the HP 129Xe(aq) peak. Using a customized EXSY pulse sequence [28], the
Xe@TAAC resonance was selectively excited and acquired twice (separated by des-
ignated mixing times), generating two FIDs (initial and recovery). The ratio of
signal intensities was calculated to quantify the percentage of Xe@TAAC replen-
ishment, at a manually set mixing time that’s close to the xenon exchange lifetime
being fitted. With a series of exchange-replenishment ratios and their correspond-
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ing mixing times, Xe exchange lifetime can be fitted, providing a measurement of
cryptophane-Xe exchange performance.
4.3 Results and Discussion
4.3.1 Hyperpolarized 129Xe NMR Spectra of TAAC in Aque-
ous Solution
Two peaks arise in the HP 129Xe NMR spectrum of 140 µM TAAC aqueous solution
(Figure 4.2): Xe dissolved in water at 320 K (Xe(aq), 194.3 ppm) and Xe bound in
TAAC (Xe@TAAC, 65.8 ppm). In HP 129Xe detection schemes investigated to date,
there is a large excess of Xe (mM) relative to cryptophane (µM) [97], which results
in a Xe(aq) peak that is ∼1000 times stronger than Xe@TAAC without selective
excitation. Given the almost 130 ppm separation of the two peaks, selective RF
pulses focused on Xe@TAAC will have little effect on Xe(aq) under most conditions,
which allows selective excitation of the minor “cryptophane-bound” species as well
as selective saturation exchange experiments.
Direct detection, even selective excitation (for example, Figure 4.2), requires mi-
cromolar cryptophane, which limits cryptophane biosensor experiments to prevalent
biological targets. Some cryptophanes may also be toxic to cells at this concentra-
tion [25,26]. Instead of trying to detect directly the Xe@TAAC peak, the Xe@TAAC
resonance can be indirectly measured more sensitively via magnetization transfer
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from the much stronger Xe(aq) signal.
Xenon binding kinetics of TAAC. The thermodynamics of xenon binding is es-
tablished by the equilibrium shown in eq4.3.1:
Xe+S@TAAC
kon
GGGGGGGGBF GG
koff
Xe@TAAC + S (4.3.1)
where S@TAAC indicates solvent-bound TAAC. It is experimentally observed
[98] that “empty” cryptophane is preferably bound with solvent, in this case one
or multiple water molecules. Because the concentration of solvent is constant, the
reverse process in eq4.3.1 can be simplified to be first-order, yielding constant “koff”
(koff [S]). This yields eq4.3.2 with the rate constants of xenon binding (kon) and
dissociation (koff ) indicated:
kon[Xe][TAAC] = koff [Xe@TAAC] (4.3.2)
The maximal Hyper-CEST effect should occur under conditions where all of
the cryptophane is encapsulating xenon (to ensure maximal Xe absorption of the
RF pulse) while still allowing the most rapid “Xe in”-“Xe out” exchange. The
xenon on- and off-rates (kon, koff ) describe the rates at which HP Xe gains access
to the cavity of TAAC and the rate at which depolarized Xe leaves TAAC. This
exchange process should occur most rapidly when a HP Xe atom directly displaces
depolarized Xe, with no intermediary solvent binding. However, because TAAC
experiments are conducted in water, solvent may compete with Xe binding.
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4.3.2 Ultra-sensitive Detection of TAAC
Picomolar TAAC was detected by a series of Hyper-CEST measurements, following
the general method developed in the Pines lab. [92] In Figure 4.4 on page 77, relative
intensity of Xe(aq) signal was plotted against the time of saturation transfer pulse
cycles, which is representative data from three trials. As in Figure 2.6, the shaped
saturation pulse was configured to resonate at the frequency of Xe@TAAC signal
(65.8 ppm). As a control, saturation at a mirror frequency (2×194.3−65.8 = 322.8
ppm) was established, to perform off-resonance Hyper-CEST. When the satura-
tion pulse was tuned to Xe(aq) frequency, the peak was able to be completely
saturated with 2 scans. At 14 pM TAAC concentration and higher, on-resonance
Hyper-CEST clearly presented a more sharply decaying Xe depolarization curve,
indicating effective saturation transfer. After 10-fold dilution, the difference in de-
polarization rate was still observable from exponential fits (Figure 4.4, due to the
instability of data, we didn’t achieve good measurement of depolarization lifetime.
However the clear difference between on- and off- resonance are verified). Detection
of 1.4 pM TAAC is currently the lowest observed concentration for a single-unit Xe
host. Previously, the Pines lab demonstrated detection of 10 nM cryptophane using
this technique [99]. To explain the much greater detection sensitivity obtained in
the current experiment, we hypothesized that TAAC must have much more rapid
xenon exchange kinetics compared to previously measured cryptophane systems, in
addition to its favorably high Xe@TAAC occupancy. To explore the origins of the
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achieved sensitivity, a series of characterization experiments was performed.
4.3.3 ITC Measurement of Xenon Binding to TAAC
TAAC should be favorable for Hyper-CEST NMR based on its high Xe affinity.
Moreover, its strongly positive entropy of Xe binding (S = 5.9 cal ·mol−1 ·K−1)
at 293 K) supports high affinity as temperature increases from rt to physiological
conditions [24]. Indeed, ITC measurements performed at 310 K showed the Xe-
TAAC association constant to be 33 000 ± 2000 M−1 (Figure 4.5), the same value
determined at 293 K [24]. During the Hyper-CEST experiment, xenon concentration
[97] is calculated to be 0.12 mM by assuming the hyperpolarized Xe gas mixture,
at 1 atm, saturates the sample solution. Therefore, more than 80% of the TAAC
molecules were bound to Xe, which is higher than the 45-60% host occupancy in
previous Hyper-CEST NMR experiments [30,99,100].
4.3.4 Xe@TAAC NMR Line Widths at Different Tempera-
tures
Spectra were acquired for 140 µM TAAC aqueous solution following the same
method as Figure 4.2, at different temperatures (see Table 4.1). The spectra were
Lorentzian deconvolved to fit for full width at half maximum (FWHM). Peak widths
of the Xe@TAAC peaks were corrected by subtracting the Xe(aq) peak line widths
to account for magnet inhomogeneity.
66
4.3.5 Xenon Exchange Lifetime Measurement
Previously, Xe-cryptophane exchange rates in organic solution were measured by
2D 129Xe NMR [95] spectroscopy and approximated by measuring the line width of
the Xe@cryptophane NMR resonance [86]. Due to the high concentrations of xenon
and cryptophane that dissolved in C2D2Cl4 [95], it was possible to use the small
129Xe polarization provided by the NMR magnet. Here, in order to examine the
origins of the heightened cryptophane-mediated HP 129Xe depolarization achieved
with TAAC, we sought to measure the xenon-cryptophane exchange kinetics in
aqueous solution by the combination of NMR selective excitation and 129Xe hy-
perpolarization, which was demonstrated previously for a biotin-derivatized xenon
biosensor [28].
By altering the exchange mixing time, a series of Xe replenishment efficiencies
was measured (Figure 4.9). The xenon exchange lifetime, τexch, was determined to
be 22 ± 3 ms at 297 K. This τexch value is shorter than measured for all previous
cryptophanes in water close to rt [28, 70, 88, 89]. Using the measured τexch and
KA, xenon dissociation and association rate constants were determined at 297 K:
koff ≈ kexch = 1/τexch = 45 ± 15 s−1 and kon ≈ 1.5× 106 M−1 · s−1. As kexch
is an intermolecular process [86], it likely underestimates the Xe dissociation rate
(koff ) [28]. Despite this difference, the measured rates are more than 2-fold faster
than the exchange rates measured for water-soluble cryptophanes with comparable
Xe affinity (kon = 3.8× 105 M−1 · s−1; koff = 13.1 s−1 at 293 K [88, 89];). Our
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measured exchange rates with TAAC in water are more typical of cryptophane-A
derivatives in organic solvent, where millisecond timescales have been observed [28].
A key difference, however, is that in large organic solvents such as C2D2Cl4, the
cryptophane should remain empty during the Xe exchange process. In water, solvent
binding to TAAC will slow the Xe exchange process, with koff likely reflecting the
rate-limiting step of water dissociation, followed by Xe binding (kon).
It has been established by Pines and co-workers that Hyper-CEST becomes
dramatically more sensitive at temperatures slightly above rt [99], but the origin
of this effect requires further investigation. Using our experimental setup, we were
unable to measure the exchange rate (1/τexch) exactly at 320 K, where the Hyper-
CEST experiment was performed. However, HP 129Xe NMR spectra collected at
different temperatures (Table 4.1) provide estimates for kexch from Xe@TAAC peak
line widths: kexch = 1100 s
−1 at 320 K, kexch = 500 s−1 at 310 K, kexch = 86
s−1 at 300 K, which is in reasonable agreement with the 1-D EXSY exchange rate
measurement at 297 K (kexch = 45 s
−1). Because of the high concentration of water
(55 M) in the TAAC solution, the exchange rate is limited by the dissociation rate
of water en route to Xe binding.
4.3.6 Description of HP Xe Depolarization Rate
In the overall depolarization “reaction”, resulting in thermal equilibration of all
xenon nuclear spins in solution, TAAC (together with selective saturation RF
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pulses) acts as a “spin catalyst”. When depolarization curves are fit using first-
order kinetics, the TAAC-mediated HP Xe depolarization rate constant (kTAAC)
and the natural T1 relaxation rate constant (k1) both contribute to the observed
loss of HP Xe. By multiplying kTAAC by the starting HP Xe concentration (3.1 µM),
the maximum HP Xe depolarization rate can be expressed as kTAAC×[HP Xe] =
0.17 M · s−1. After dividing by TAAC concentration (14 pM), this equates to kcat =
1.2× 104 HP Xe-129 atoms depolarized by each TAAC molecule per second. Com-
pared to a virus-capsid-based biosensor which we calculate to have kcat = 1.3× 102
s−1 [30], TAAC is observed to have 100-times greater activity on a per-cryptophane
basis.
For TAAC, which is 80% bound with Xe in solution, the Xe-Xe exchange rate
should be the critical kinetic parameter for determining Hyper-CEST efficiency.
Based on very efficient saturation transfer (¿ 0.9 in a control experiment), we assume
in our analysis of TAAC that kcat approximates the Xe-Xe exchange rate. At 320
K this is one order of magnitude faster than koff , the proposed Xe-H2O exchange
rate measured by NMR linewidth.
This suggests that there are two different kinetic processes, with only the slower
H2O-Xe exchange process being directly observable by either 1-D EXSY or NMR
linewidth measurements. Such millisecond exchange processes are most consistent
with previously published Hyper-CEST NMR results [30, 71, 85, 100], which led to
detection of nanomolar cryptophane concentrations.
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Some of TAAC’s advantage in a Hyper-CEST detection scheme may arise from
differences in cryptophane structure; for example, greater water solubilization of
TAAC should promote more open, Xe-accessible conformations of the cryptophane,
with high xenon on- and off-rates [12]. Our previous fluorescence lifetime studies
indicated that only 5-10% of TAAC in aqueous solution adopts a more collapsed,
non-Xe binding conformation [24]. In addition, high Xe occupancy and narrower
line widths for the HP 129Xe-cryptophane complex promote RF saturation leading
to efficient HP 129Xe depolarization.
4.3.7 Depolarization Mechanisms
Multiple processes may contribute to rapid Xe depolarization, beyond the discussed
Hyper-CEST Xe-cryptophane-water exchange mechanism (Scheme 4.3). Weak dipole-
dipole interactions between 129Xe nuclear spins discount the possibility for through-
space depolarization effects. However, there may be significant chemical shift
anisotropy of the xenon atom(s) associated with TAAC, which would significantly
accelerate relaxation of 129Xe nuclei [101, 102]. In addition, with induced electron
currents in the bound Xe@TAAC complex [103], meaningful variations of xenon lo-
cal magnetic fields can be present, providing another depolarization pathway [104].
However, neither effect can explain the 10-fold discrepancy between koff measured
by NMR linewidth (all Xe isotopes) and the faster kcat Xe depolarization rate de-
termined by Hyper-CEST.
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We surmise that the exchange rates that are measurable by either 1-D EXSY
or NMR line widths are not measuring the pairwise Xe-Xe exchange rate, but
instead a slower process involving the exchange of Xe for intermediary solvent in
the 20% of “empty” (water-bound) TAAC molecules. To consider the potential
for a much faster Xe-Xe exchange process, we note the previous observation that
Xe exchange rates for cryptophanes in organic solution are accelerated at higher
Xe concentrations, indicating an “associative” exchange mechanism [86]. Direct
Xe-Xe exchange may be critical for avoiding a solvent-bound “kinetic trap”, which
we propose should deactivate cryptophane for efficient Hyper-CEST.
Notably, 1.4 pM TAAC detection sensitivity was achieved with natural isotopic
abundance Xe (26.4% 129Xe) polarized to 10-15%. Thus, most of the TAAC host
molecules in solution were occupied with other “silent” Xe isotopes or “thermally
polarized” 129Xe nuclei not contributing to bulk magnetization. At the initiation of
the experiment, TAAC-bound HP 129Xe concentration was estimated to be: [TAAC]
×TAAC occupancy percentage × 129Xe isotopic abundance × hyperpolarization
level = 1.4 pM ×80%×26.4%×10% = 0.03 pM. Our analysis predicts that at least
10-fold greater detection sensitivity may be achieved for TAAC bound with more
highly polarized (50%), isotopically-enriched (86%) 129Xe — conditions that should
allow more efficient depolarization of 129Xe by RF pulses, “catalyzed” by TAAC.
In this way, femtomolar detection of TAAC and related xenon-binding molecules
should be readily achievable.
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4.4 Conclusions
Using 129Xe Hyper-CEST NMR spectroscopy, we detected a water-soluble crypto-
phane TAAC at concentrations as low as 1.4 pM, through enhancement from fast
chemical exchange. This is a uniquely sensitive NMR measurement, and, in particu-
lar, represents a roughly 100-fold improvement in detection sensitivity over recently
published 129Xe Hyper-CEST NMR data, on a per cryptophane basis [30]. To in-
vestigate the role of TAAC in improving detection sensitivity, Xe binding kinetics of
TAAC were characterized for the first time, by combining exchange lifetime with as-
sociation constant measurements. Favorable thermodynamic and kinetic properties
of Xe binding to TAAC were determined.
Kinetic analysis of Hyper-CEST NMR experiments with TAAC revealed a rapid,
TAAC-mediated 129Xe depolarization mechanism (kTAAC [HP
129Xe] = 1.7 × 10−7
M · s−1), which corresponds to 1.2×104 HP 129Xe atoms depolarized per second. As-
suming near unity saturation efficiency, this corresponds to one order of magnitude
faster Xe exchange than koff measured by 1-D EXSY and linewidth NMR measure-
ments, which we assign to HP 129Xe exchanging with H2O in the cryptophane cav-
ity. We propose that the sub-millisecond kinetic process inferred from Hyper-CEST
NMR experiments at 320 K can be assigned to efficient Xe-Xe exchange. Ongoing
theoretical calculations and experiments using different cryptophane moieties are
investigating the significance of these two possible Xe-cryptophane exchange path-
ways. We conclude that ultrasensitive cryptophane detection supports the further
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development of xenon host molecules and cryptophane-based biosensors for in vitro
and in vivo 129Xe magnetic resonance studies.
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Figure 4.1: Triacetic acid cryptophane-A derivative (TAAC).
Table 4.1: Line width of 129Xe@TAAC NMR peak at various temperatures, and
estimated Xe exchange rates.
Temperature (K) Line width of 129Xe@TAAC peak (Hz)* Estimated kexch (s
−1)
300 27.3 ± 1.1 86 ± 3.4
310 157.3 ± 1.1 500 ± 3.4
315 238.3 ± 3.6 750 ± 11
320 342.2 ± 5.7 1100 ± 18
325 294.2 ± 3.2 920 ± 10
*Magnetic homogeneity corrected.
74
Figure 4.2: HP 129Xe NMR spectrum of 140 µM TAAC dissolved in ultrafiltered
water at 320 K, showing: Xe(aq) peak at 194.3 ppm and Xe@TAAC peak at 65.8
ppm (selectively excited). Lorentzian deconvolved spectrum is shown in red.
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Figure 4.3: Saturation transfer processes in 129Xe Hyper-CEST NMR with cryp-
tophane.
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Figure 4.4: Representative 129Xe Hyper-CEST profiles (from 3 trials) of 14 pM and
1.4 pM TAAC at 320 K plotted as the Xe(aq) peak intensities vs. saturation time.
Differences between on- and off-resonance saturation are compared. Exponential
fits of data are shown as red and dark curves. Depolarization lifetimes were fitted
to be 10 ± 1 s (on) and 38 ± 2 s (off) for 14 pM sample (averaged over two trials); 53
± 4 s (on) and 65 ± 4 s (off) for 1.4 pM sample (representative trial), respectively.
In each experiment, a series of 2.6 ms DSnob pulses with 20 s delay was applied.
In the Hyper-CEST pulse sequence, the following parameters were used: sp6 = 2.6
ms, d12 = 20 µs, d1 = 1 µs, L6 = 8 000 (max, 14 pM) or 10 000 (max, 1.4 pM).
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Figure 4.5: Enthalpogram of 3.31 mM aqueous xenon solution titrated into 131 µM
TAAC solution (phosphate buffer, 20 mM, pH 7.5) at 310 K.
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Figure 4.6: ITC buffer controls at 310 K. Water titrated into 20 mM phosphate
buffer, pH 7.5.
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Figure 4.7: ITC buffer controls at 310 K. Water titrated into a solution of 131 µM
TAAC in 20 mM phosphate buffer, pH 7.5.
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Figure 4.8: ITC buffer controls at 310 K. Xenon-saturated water (3.31 mM) titrated
into 20 mM phosphate buffer, pH 7.5.
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Figure 4.9: Xe-TAAC exchange lifetime measurement by selective EXSY at 297 K.
The horizontal axis denotes the mixing time between two consecutive excitations.
The vertical axis indicates the ratio of the integrated intensities of Xe@TAAC sig-
nals, exchange recovered vs. equilibrium. Data were exponentially fitted to give an
exchange lifetime, τexch = 22 ± 3 ms. This exchange lifetime is in good agreement
with linewidth measurements made at 300 K (Table4.1).
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Chapter 5
Anthrax Detection and Bacterial
Spore Analysis Using 129Xe
Hyper-CEST NMR
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5.1 Background
A subset of bacteria produce a highly resistant, dormant cell type, called the spore,
which is produced in response to specific stresses, most notably starvation [105].
Although essentially metabolically dormant [106], the spore can break dormancy
(a process called germination) very soon after the spore detects specific signals (in-
cluding, in some species, amino acids) that likely indicate conditions for resuming
growth are present. A small fraction of spore-forming species are pathogenic, in-
cluding Clostridium difficile, one of the most important health-associated infectious
agents [107], as well as Bacillus anthracis, a major biothreat agent [108]. The threat
posed by these and other pathogenic species has intensified efforts to better under-
stand the roles of spore structures in resistance, and to improve methods of spore
detection. The spore’s unusual—and incompletely understood—structural integrity
in the face of extreme temperatures, mechanical stress, chemical denaturation and
other stresses is essential to maintaining viability as well as resisting host defense
and decontamination [109]. A molecular understanding of how the structures en-
casing the spore provide this protection has been a goal of basic research for many
decades [106]. Here, we demonstrate a 129Xe nuclear magnetic resonance (NMR)
spectroscopic method that allows both sensitive analysis and detection of intact
spores in aqueous solution, without any further sample preparation.
Spores have a distinctive architecture, composed of a series of concentric layers,
each of which contributes to resistance and other spore properties (Figure 5.1a,
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b) [109, 110]. In some species, including B. anthracis, the outermost spore layer is
the exosporium, a pleomorphic shell composed of proteins and glycoproteins (Fig-
ure 5.1a). The exosporium is present in pathogenic and nonpathogenic species (for
example, see Traag et al. [111]). Beneath the exosporium (and separated by a gap)
is the coat, which is present in all bacterial spores (Figure 5.1b) [110]. Although
these two layers play key roles in spore resistance, their chemical properties and
molecular organization remain incompletely understood. This lack of information
hinders efforts to improve anti-spore therapeutics, decontamination and spore de-
tection. In particular, sensitive methods for spore detection that do not require
major sample preparation and discriminate between pathogenic and nonpathogenic
spore-forming species are needed. No existing method achieves all these goals. In
particular, identifying species without DNA sequencing has been especially chal-
lenging. For example, fluorescence-based assays have been developed that readily
detect bacterial spores [112–116], but cannot discriminate between species, because
the target analyte, dipicolinic acid (DPA), is present in bacterial spores of all species.
Methods that identify subcellular structures in spores that vary among species (and,
in particular, between at least certain pathogenic and non-pathogenic species) could
be very helpful to improved pathogen detection.
NMR spectroscopy has been used previously to analyze spore contents [117–119]
but typically offers limited detection sensitivity, due to small polarization of the
nuclear spin reservoir, where the difference in spin populations aligned parallel or
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anti-parallel to an external magnetic field at thermal equilibrium is typically just
10 in a million nuclei. Thus, significantly enhanced NMR signals can be obtained
via hyperpolarization techniques capable of generating a nuclear spin polarization
level approaching 100% [37, 120]. Our laboratory [21, 23, 24, 56, 121] and others
[27,29,55,85,92,100,122–128] have explored the noble gas nucleus 129Xe, which has
one-half nuclear spin number (I = 1/2), and can be hyperpolarized (HP) to near unity
by spin-exchange optical pumping [129]. To make the technique more sensitive for
demanding applications, chemical exchange provides another source of NMR signal
amplification. When exchanging magnetic species are present, chemical exchange
saturation transfer (CEST) can achieve signal amplification based on cumulative
magnetization transfer through selective saturation [13]. This gives the possibility
of designing extremely sensitive contrast agents that respond to various exchange
events, with techniques known as PARACEST [130] and LIPOCEST [84]. More
recently, the analogous technique involving HP 129Xe (Hyper-CEST) was developed
[85]. Until now, this technique has only been applied to 129Xe exchange between
bulk aqueous solution and high-Xe-affinity, water-soluble organic host molecules
(i.e., cryptophanes) or organic solvents. This work provides the first demonstration
of using Hyper-CEST 129Xe NMR to interrogate the structure of a biological sample.
Here we present Hyper-CEST NMR analysis of wild type and mutant B. an-
thracis and B. subtilis spores, where detection limits of 105-109 spores per milliliter
were achieved in aqueous solution. 129Xe gas irradiated by radio frequency pulses
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in the spore interior efficiently transfers loss of magnetization to the bulk solu-
tion, which provides contrast between different spore structural components. We
analyzed strains of B. anthracis that vary in exosporium structure and strains of
B. subtilis that vary in coat structure. These strains show readily distinguishable
Hyper-CEST behaviors, in a manner consistent with the hypothesis that spore lay-
ers cause variations in the rate of xenon diffusion between aqueous solution and the
spore interior. We speculate that these signature differences are the consequence of
as yet poorly understood chemical and structural features of the exosporium and
coat. By determining the Xe accessibility of the spore interior to the outer environ-
ment, Hyper-CEST NMR provides a rapid, nondestructive measure of molecular
porosity. Importantly, this methodology distinguishes between spores with and
without exosporia. As a result, in combination with other technologies, it could be
a component of a novel method or device to identify B. anthracis spores.
5.2 Results and Discussions
5.2.1 Strains
All strains are in either the attenuated Sterne strain 34F2 (for B. anthracis) or PY79
(for B. subtilis) backgrounds. The B. anthracis strain ADL986 lacks the exosporium
(due to a mutation in cotE ) and the strain ADL2260 possesses the innermost layer
of the exosporium (the basal layer) but lacks the hair-like projections or nap that
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project from the basal layer-outer surface, due to BclA mutation [131, 132]. The
B. subtilis strains ADL25 and ADL57 lack the outer layers of the coat, or almost
the entire coat, due to mutations in cotE, or cotE and gerE, respectively [133,134].
We note that while the genes both named cotE in B. anthracis and B. subtilis are
indeed orthologous, their mutant phenotypes have important differences between
these two species, as noted.
5.2.2 Hyper-CEST Experiment with Spores
Before starting the Hyper-CEST experiment each time, fresh HP Xe was delivered
into a 10 mm thick NMR tube, and bubbled through a 3-mL liquid sample. Right
before the pulse sequence started, HP Xe bubbling was stopped by a couple of
solenoid valves to stabilize the liquid sample for NMR acquisition. The NMR tube
was airtight during the Hyper-CEST experiment, which is achieved by a homebuilt
continuous-flow HP Xe delivery setup [121].
Figure 5.1c illustrates the Hyper-CEST experiment involving spores. As a start-
ing point for all sets of Hyper-CEST experiments, a consistent amount of fresh HP
Xe resides in the sample suspension. As the first step of the Hyper-CEST pulse
sequence, DSnob-shaped 180-degree selective pulses were looped numerous times
continuously, at frequencies of interest. Pulse power was calibrated to give max-
imum saturation performance. Xenon resonances within the RF pulses selected
frequency range were depolarized, with the aid of chemical exchange, thereby ac-
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celerating depolarization of the whole xenon sample. After the overall polarization
was reduced by saturation pulses and chemical exchange, the sample was irradiated
with a 90-degree hard pulse to observe the final magnetization state of 129Xe in
solution. More detailed description for the pulse sequence can be found in Figure
2.6.
5.2.3 Hyper-CEST Profile for Spores
Multiple (100-500) selective 180-degree radio-frequency (RF) pulses were delivered
to spore samples at the various resonance frequencies, within a duration between 1.0
s and 9.5 s. By scanning the saturation frequencies, different Xe(aq) signal intensi-
ties were acquired and plotted as the exchange profile. At frequencies of observable
Xe depolarization, HP Xe and depolarized Xe were dynamically exchanging among
distinguishable chemical environments related to spores.
Figure 5.2 shows the profile of wild type B. anthracis at 1.2× 109 cfu/mL, in
188-203 ppm frequency range, and at 0.5 ppm resolution. A Xe(spore) signal was
observed to be actively exchanging with the Xe(aq) signal. After the profile was
fit by Voigt line shape, two signals were found. The secondary peak at 196.3 ppm
(7.6 ppm wide) is assigned to Xe(spore); while the main peak at 193.4 ppm (4.5
ppm wide) is assigned to Xe(aq). Similar profiles are also observed for all spore
samples listed above (Figures 5.4, 5.5, 5.6, 5.7, 5.8), at a much lower density of
1.2× 107 cfu/mL. The Xe(spore) peak chemical shifts are summarized in Table 5.1.
89
Except for B. anthracis, all Xe(spore) signals were found at 198 ± 1 ppm. This
small difference may be attributable to the intact exosporium present in wild type
B. anthracis and not in the other strains analyzed.
5.2.4 Depolarization Rate Measurement for Spores
To make comparison between Hyper-CEST performances across spore strains, and
to make the CEST effect more observable, HP Xe depolarization background needs
to be removed. Two frequencies, 197.5 ppm and 188.9 ppm, were selected for Hyper-
CEST “on” and “off” resonance, and kept the same in the two series of data points.
The number of saturation pulses in the sequence was increased from 0 to 2000 in
steps of 200 (Figure 5.3a), corresponding to saturation times between 0 s and 38
s. Meanwhile, the Xe(aq) signal decreased exponentially as more pulse power was
applied to the sample. The exponential decay time (T1) of HP Xe, for the two
selected frequencies, can be extracted from fitting the decay curves. In Figure 5.3,
the decay time constants were fitted to be 16.5 s (on) and 29.6 s (off). The existence
of chemical exchange with the “on resonance” group greatly accelerated the rate.
5.2.5 Saturation Transfer Efficiency (Hyper-CEST contrast)
A more direct way to quantify the contrast generated by the Hyper-CEST ex-
periment is to compute the saturation transfer efficiency (ST ), which is directly
proportional to MR image contrast:
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ST =
∑
k
Ikoff − Ikon
Ikoff
Lk∑
k′
Lk′
(5.2.1)
In equation 5.2.1, I represents the integral of Xe(aq) signal acquired in a Hyper-
CEST experiment with set saturation frequency, duration, and power. L represents
the duration of Hyper-CEST pulse sequences, which is the sum of time spent in
shaped saturation pulses and delays. The summing index k indicates the experiment
number in Figure 5.3a. This weighted sum, corresponding to ST , provides the
proportion of saturation-transferred magnetization, over the initial value. Therefore
ST quantifies the efficiency of the Hyper-CEST experiment for each sample.
5.2.6 Enhanced Hyper-CEST from Mutated Exosporium
We analyzed one B. anthracis strain lacking the exosporium (strain ADL986, with
mutation in cotE [132]) and one missing the major exosporium protein BclA (strain
ADL2260) [131]. B. subtilis spores lack an exosporium. In Table 5.1, ST is listed
for all strains at 1.2× 107 cfu/mL. Both strains gave dramatically enhanced Hyper-
CEST contrast. Strain ADL986 had exosporium removed strongly increased sensi-
tivity to Hyper-CEST, consistent with the interpretation that the lack of the hair-
like projections on the exosporium surface increases sensitivity to Hyper-CEST.
Significantly, detection of wild type B. anthracis by Hyper-CEST required a 100-
fold higher concentration than the other strains.
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5.2.7 Enhanced Hyper-CEST from B. subtilis Spores with
Coat Defects
To determine whether Hyper-CEST can be used to monitor also the molecular
features of the spore coat, we analyzed wild type B. subtilis and strains lacking
the outer layers or almost all of the coat (strains ADL25 and ADL57, respectively)
[133,134]. We found that in the absence of the outer layers of the coat, the Hyper-
CEST contrast was enhanced by more than 2-fold (comparing PY79 and ADL25,
Figure 5.3b). In strain ADL57 (lacking almost the entire coat), we measured an
additional 2-fold increase in Hyper-CEST contrast. We conclude that spores lacking
coat layers are more sensitively detected by Hyper-CEST. We infer that this increase
is due to the spore interior being more accessible to xenon in solution. To measure
the limit of detection of the most Xe-accessible strain, we performed Hyper-CEST
on ADL57 at concentrations from 104 to 106 cfu/mL. A clear Hyper-CEST contrast
was observable at 105 cfu/mL (Figure 5.9).
5.2.8 Possible Origin of Xenon Exchange in Spores
With a ∼4.3-angstrom diameter, and a very polarizable electron cloud, Xe is known
to exhibit affinity for sub-nanometer-sized void spaces in materials, proteins, and
organic cages [16, 17, 135, 136]. Xe is also very sensitive to its environment, as
reflected by the 4 ppm chemical shift difference between the Xe(aq) and Xe(spore)
NMR peaks. Our data are consistent with xenon occupying sites in the spore
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interior, where the chemical shift will differ from water and result in a reservoir for
exchange behavior. Experiments are underway to verify the primary site(s) occupied
by Xe in the spore interior. However, as highlighted above, spores with fewer outer
layers presented stronger Hyper-CEST contrast. The best contrast was observed
with strain ADL57, which largely lacks the coat. This argues that the cortex, inner
membrane and/or core are the site(s) of Xe exchange. Notably, by producing a
discrete Xe-bound resonance frequency, the spore must possess a significant number
of Xe binding sites, albeit likely with low Xe affinity (KA ∼ 10-100 M−1, as seen
for many proteins [48–51]). The core, the inner-most spore compartment, is one
likely site of Xe occupancy, as it contains compacted, dehydrated DNA buried in
crystalline Ca2+-dipicolinic acid [109]. Additionally, the exchange rate must be fast
compared to the timescale of the HP 129Xe longitudinal relaxation time (T1 ∼75 s)
in order to produce the observed enhancement in detection sensitivity relative to
direct detection schemes. Notably, no “bound” 129Xe NMR signal is observed for
any of the spore samples at concentrations of 1.2× 107 cfu/mL.
These findings argue that the bacterial spore interior is accessible to small hy-
drophobic molecules of the size of Xe. Small molecules, such as methane, which
differ somewhat from Xe in size, hydrophobicity, and diffusion rate, may also be
able to penetrate through the spore protection layers, giving further opportunity to
analyze the spore structure.
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5.3 Methods
5.3.1 NMR Sample Preparation
Spores were prepared as described in previous references [132]. Spore number
was measured by counting colony-forming units. Before each NMR experiment,
the spores were suspended in MilliQ water to desired number densities (1.2× 109
cfu/mL for strain 34F2, 1.2× 107 cfu/mL for all samples, and 1.2× 104 -1.2× 107
cfu/mL for ADL57).
5.3.2 Hyperpolarized 129Xe NMR Setup
All NMR spectra were acquired by a Bruker BioDRX 500 MHz NMR spectrometer.
RF pulse frequency for 129Xe was 138.12 MHz. Spore suspension samples were
observed using a 10-mm PABBO NMR probe. HP 129Xe was generated using a
home-built 129Xe hyperpolarizer, based on the commercial model IGI.Xe.2000 by
GE. A gas mixture of 89% nitrogen, 10% helium, and 1% natural abundance xenon
(Linde Group, NJ) was used as the hyperpolarizer input. 129Xe was hyperpolarized
to 10-15% after optical pumping of Rb vapor with 795 nm circularly polarized laser.
Sample temperature was controlled by VT unit on NMR spectrometer to 278 ± 1
K. All acquired NMR spectra using the Hyper-CEST pulse sequence were processed
with 10 Hz Lorentz broadening. Xe(aq) signal intensities under different saturation
frequencies and/or times were integrated and relative values were used for further
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derivations.
5.4 Conclusions
We have successfully analyzed various bacterial spores using a sensitive Hyper-
CEST NMR technique. The ability of Xe to diffuse readily within the spore layers
and interact with the interior to give rise to Hyper-CEST signal (without cryp-
tophane or other engineered binding sites), suggests many new applications for
Hyper-CEST NMR in biophysics and materials science. In this example, the most
Xe-accessible spores were detected at a concentration of just 105 cfu/mL, which is
∼7 orders of magnitude more sensitive than previous efforts at spore detection using
NMR [117,118]. Moreover, this result did not require specialized sample preparation
and was achieved without spore destruction, thereby allowing downstream analysis
of the sample.
The finding that the Hyper-CEST signal increased in spores where outer struc-
tures were absent strongly suggests that Xe in aqueous solution gains ready access
to the interior in a manner such that the rate of the exchange process depends on
the thickness and/or composition of the outer layers present. We note, therefore,
that Hyper-CEST could be an especially powerful method to distinguish between
spores that are morphologically similar, but differ in characteristics that mediate
Xe exchange, and that this technique also provides a novel method for spore de-
tection. The finding that the exosporium effectively limits Xe entry into the spore
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is notable and is consistent with the view that the exosporium acts as a molecular
sieve. Taken as a whole, our results show that Hyper-CEST NMR provides a novel
method for noninvasive spore detection and a powerful tool for probing the phys-
ical and chemical properties of the spore interior. We argue that, in combination
with genetic manipulation of spore ultrastructure, Hyper-CEST can generate new
insights into spore composition and function that have previously been difficult or
impossible to analyze.
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Figure 5.1: 129Xe Hyper-CEST experiment with spores. a) B. anthracis strains: (A)
34F2, (B) ADL2260, (C) ADL986; b) B. subtilis strains: (D) PY79, (E) ADL25,
(F) ADL57; c) Scheme showing Hyper-CEST experiment with spores.
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Figure 5.2: Hyper-CEST profile of wild type B. anthracis spore at 1.2× 109 cfu/mL
with 600 pulse cycles for saturation exchange (11.6 s saturation time). Profile
acquired at 0.5 ppm resolution, at 278 K. Two peaks (193.4 ppm and 196.2 ppm)
are shown for the water and spores, respectively.
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Figure 5.3: Hyper-CEST saturation transfer efficiency across spore strains. a)
Hyper-CEST depolarization curve of wild type B. anthracis spores at 1.2× 109
cfu/mL. Saturation frequencies were 197.5 = (193.2 + 4.5) ppm and 188.9 =
(193.2 − 4.5) ppm, for “on” and “off” resonance, respectively. Decay time con-
stants (T1) were determined to be 16.5 s (on) and 29.6 s (off). b) Comparison of
saturation transfer efficiencies across six spore strains. All strains were observed at
1.2× 107 cfu/mL.
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Figure 5.4: (a) Hyper-CEST profile of B. anthracis ADL2260 spores at 1.2× 107
cfu/mL with 300 pulse cycles for saturation exchange; (b) Hyper-CEST depolariza-
tion curve of B. anthracis ADL2260 spores at 1.2× 107 cfu/mL.
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Figure 5.5: (a) Hyper-CEST profile of B. anthracis ADL986 spores at 1.2× 107
cfu/mL with 200 pulse cycles for saturation exchange; (b) Hyper-CEST depolariza-
tion curve of B. anthracis ADL986 spores at 1.2× 107 cfu/mL.
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Figure 5.6: (a) Hyper-CEST profile of B. subtilis PY79 spores at 1.2× 107 cfu/mL
with 200 pulse cycles for saturation exchange; (b) Hyper-CEST depolarization curve
of B. subtilis PY79 spores at 1.2× 107 cfu/mL.
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Figure 5.7: (a) Hyper-CEST profile of B. subtilis ADL25 spores at 1.2× 107 cfu/mL
with 200 pulse cycles for saturation exchange; (b) Hyper-CEST depolarization curve
of B. subtilis ADL25 spores at 1.2× 107 cfu/mL.
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Figure 5.8: (a) Hyper-CEST profile of B. subtilis ADL57 spores at 1.2× 107 cfu/mL
with 200 pulse cycles for saturation exchange; (b) Hyper-CEST depolarization curve
of B. subtilis ADL57 spores at 1.2× 107 cfu/mL.
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Figure 5.9: (a) Hyper-CEST depolarization curve of B. subtilis ADL57 spores
at 1.2× 105 cfu/mL. (b) Hyper-CEST depolarization curve of B. subtilis ADL57
spores at 1.2× 106 cfu/mL.
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Table 5.1: Saturation transfer (ST ) efficiency and exchange signal chemical shift
for six spore strains.
Spore Strain Saturation
Transfer
Efficiency
129Xe(spore)
NMR signal
chemical shift
(ppm)
B.anthracis 34F2 0.01 196±8
B.anthracis ADL2260 0.15 199±2
B.anthracis ADL986 0.08 198±1
B.subtilis PY79 0.10 198±1
B.subtilis ADL25 0.22 199±2
B.subtilis ADL57 0.48 197±1
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Chapter 6
Summary
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This thesis aimed to increase the applicability of 129Xe NMR/MRI techniques
by 129Xe hyperpolarization and chemical exchange saturation transfer, for medical
and/or molecular imaging. Also, attempts were made to broaden the scope of
hyperpolarized 129Xe as a biophysical probe, for applications other than imaging.
6.1 Biosensor Multiplexing
Previous results from the Dmochowski lab and NMR studies described in this work
show that cryptophanes can be conjugated with molecular recognition moieties
(enzyme substrates, enzyme inhibitors, etc). Upon interacting with the targeted
molecule, chemical shift changes are generated in the 129Xe NMR spectrum, even
for small perturbations of protein conformation or even for a peptide undergoing
helix formation (chapter 3). The usage of a “cocktail” of multiple biosensors in the
same experiment is viable, by guaranteeing that they do not interfere in the 129Xe
NMR frequency domain under measurement.
Under the Hyper-CEST scheme, xenon is observed to exchange between differ-
ent sites at distinctive chemical shifts. Multi-site exchange behaviors arise when
biosensors targeting different biomarkers are present inside the same xenon reser-
voir. This can be a double-edged sword in many cases as biosensors may compete
for limited HP Xe, or may produce a much enhanced Hyper-CEST effect if they
work synergically. More interestingly, as many different xenon reservoirs are present
in vivo, multiplexed Hyper-CEST of the same biosensor with more than one xenon
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reservoir could potentially be observed.
6.2 In vivo 129Xe Hyper-CEST MRI
129Xe MRI has previously been applied to both lab animals and human lungs.
More, human clinical trials with various proton CEST imaging agents are currently
underway. A natural extension is the application of in vivo 129Xe Hyper-CEST
MRI. From the viewpoint of this work, two main challenges are likely to emerge.
First, the Xe concentration, hyperpolariation level, and diffusion rate need to be
determined and modeled in an imaging subject, given a particular HP Xe delivery
method. In most organisms, no endogenous Xe is observable by MRI. If the Xe MRI
scheme is not correctly predicted, the background for Hyper-CEST can report false
positives/negatives. A hollow region on a Hyper-CEST MRI may indicate contrast
generated by Hyper-CEST agents, however, it could also originate from anatomical
structures that are impermeable to Xe gas.
Second, the pulse sequences for Hyper-CEST imaging can be difficult to im-
plement. The pulse sequences and signal processing practices in conventional pro-
ton MRI, proton CEST, chemical shift imaging, and hyperpolarized 4He/13C/129Xe
MRI, are not well-suited for Hyper-CEST. For example, in HP 13C imaging, a com-
monly applied method is to use small-flip-angle pulses to signal average multiple
transients, thus minimally perturbing the hyperpolarized 13C spin reservoir. This
allows as many transients as possible, before 13C hyperpolarization level drops due
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to relaxation. However, to image Hyper-CEST contrast, the depolarization effect
is the crucial observable. If it’s necessary to acquire multiple transients for signal-
averaging, multiple HP Xe deliveries need to be employed.
6.3 Xenon As a Useful Biophysical Probe
For early cancer detection and other imaging applications using HP 129Xe, previous
and ongoing efforts have utilized synthetic organic host molecules. In the literature,
129Xe NMR has also been used in zeolite characterization, molecular host recognition
[16,17], and it also has good permeability to biological cells [29].
This thesis has demonstrated that HP Xe can be used directly in bacterial
spore structure analysis. More, it’s possible to use Hyper-CEST with analytes that
have xenon exchanging sites which resonate at a distinguishable frequency. As
mentioned previously, the exchange rate timescales of xenon must lie between the
129Xe relaxation time (100 s) and NMR sampling time interval (10−5 s). We predict
these criteria will be met by a very broad range of samples, including human tissues,
biological cells, transient forming cavities in proteins, etc.
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Appendix A
129Xe Hyperpolarizer Setup
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Figure A.2: Picture of home-built 129Xe hyperpolarizer
114
Figure A.3: Pump laser absorption profile by Rb vapor
115
Appendix B
Pulse Sequences and Source Code
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B.1 Hyper-CEST NMR Pulse Sequence
;zgps_hyper_cest
;UNIVERSAL pulse sequence for Hyper-CEST
;
;
;1D sequence with presaturation (Hyper-CEST)
;using shaped pulse for presaturation
;use shaped pulse to saturate a different freq than f1
;then turn back to observe f1 with a hard pulse
;$CLASS=HighRes
;$DIM=1D
;$TYPE=
;$SUBTYPE=
;$COMMENT=
#include <Avance.incl>
"d12=20u"
"acqt0=-p1*2/3.1416"
1 ze
2 d1
d12 fq=cnst20:f1
3 (p18:sp6 ph29):f1
d6
lo to 3 times l6
d12 pl1:f1 fq=0:f1
p1 ph1
go=2 ph31
30m mc #0 to 2 F0(zd)
exit
ph1=0 2 2 0 1 3 3 1
ph29=0
ph31=0 2 2 0 1 3 3 1
;pl1 : f1 channel - power level for pulse (default)
;sp6: f1 channel - shaped pulse for presaturation
;p1 : f1 channel - 90 degree high power pulse
;p18: f1 channel - presaturation using shaped pulse
;d12: delay for power switching [20 usec]
;l6: p18 * l6 = total duration of presaturation
;NS: 1 * n, total number of scans: NS * TD0
;use 100msec pulse of square shape defined by 1000 points
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B.2 1D EXSY NMR Pulse Sequence
;xe nmr excitation-recovery
;measure xe exchage rates in cryptophanes
;avance-version (06/12/11)
;
;pseudo 2D
;using different acquisition time to define different mixing times
;using different memory-blocks for initial and recovery spectra
;
;$CLASS=HighRes
;$DIM=2D
;$TYPE=
;$SUBTYPE=
;$COMMENT=
;
;use the au program "yb-exch-time" to acquire while change the TD,
;therefore changing AQ
;use "yb-compare2" to record the data (ratio between integrals)
;use wider excitation region than 100 Hz (Applied to TAAC)
;
#include <Avance.incl>
#include <Delay.incl>
"d11=30m"
"DELTA1=d1-d20"
1 ze
2 3m st0
d1
4u pl0:f1
(p11:sp1 ph1):f1
goscnp ph31
20u st
4u pl0:f1
(p11:sp1 ph1):f1
goscnp ph31
d11 wr #0
3m ipp1 ipp31
lo to 2 times ns
exit
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ph1=0 0 2 0 1 3 3 1
ph31=0 0 2 0 1 3 3 1
;
;f1 : channel - power level for xenon excitation
;p1 : f1 channel - 90 degree high power pulse
;d1 : relaxation delay; 1-5 * T1
;d11: delay for disk I/O [30 msec]
;l4: l4 = number of averages = (total number of scans) / NS
;NS: 8 * n
;DS: 4
;td1: number of experiments
;NBL: NBL = number of irradiation frequencies
; choose td in f1 to be 2
;
;this pulse program produces a ser-file (PARMOD = 2D)
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Appendix C
Experiment Control Programs
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C.1 Hyper-CEST Profile at Different Saturation
Frequencies
// AU program "yb-cest-profile"
// for Hyper-CEST profile scan
// use sw_ppm as the saturation frequency in ppm
// this AU program is used with pulse sequence "zgps_hyper_cest"
#include <stdlib.h>
char *envpnt;
int expTime, zgsafety, sleeptime = 20;
float sw_ppm_start = -50.0, sw_stepsize = 10.0,
sw_hz = 0.0, sw_ppm_end = 50.0, sw_ppm = 0.0;
GETFLOAT("Choose the starting chemical shift
(relative to the solvent peak):", sw_ppm_start);
GETFLOAT("Choose the ending chemical shift
(relative to the solvent peak):", sw_ppm_end);
GETFLOAT("Choose the chemical shift scan
stepwidth:", sw_stepsize);
/* Turn zg safety off if on. Turn it back on at the end. */
envpnt = getenv("UXNMR_SAFETY");
zgsafety = 0;
if(envpnt != NULL)
{
if(strcasecmp(envpnt, "on") == 0)
{
zgsafety = 1;
CPR_exec("env set UXNMR_SAFETY=off", WAIT_TERM);
}
}
/* end of zg safety */
// calculate number of exp based on freq span and step size of freq change
int NumberOfExp=(sw_ppm_end - sw_ppm)/sw_stepsize + 1;
// write parameters into a temporary par set
GETCURDATA;
WPAR("temp_yb","all");
// three blank points to eliminate the starting bias of hp xenon flow
// go to the end of the dataset by changing expno
WRA(NumberOfExp + 1);
REXPNO(NumberOfExp + 1);
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// acquire three blank points
TIMES(3)
system("closeall.exe");
sleep(sleeptime);
SETCURDATA;
RPAR("temp_yb","all");
system("openall.exe");
ZG;
// auto process current data
EFP;
APK;
XCMD("abs n");
APK;
XCMD("abs n");
APK;
XCMD("abs n");
// go to next data set
IEXPNO;
END
// go back to front of dataset
REXPNO(1);
// start acquistion of useful exp data
sw_ppm = sw_ppm_start;
TIMES(NumberOfExp)
system("closeall.exe");
sleep(sleeptime);
SETCURDATA
RPAR("temp_yb","all");
// convert ppm to Hz
sw_hz = sw_ppm * 138.24;
STOREPAR("CNST 20", sw_hz);
// increase the current scan freq
sw_ppm += sw_stepsize;
system("openall.exe");
ZG;
// auto process current data
EFP;
APK;
XCMD("abs n");
APK;
XCMD("abs n");
APK;
XCMD("abs n");
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// go to next data set
IEXPNO;
END
/* Turn zg safety on. */
if(zgsafety == 1)
CPR_exec("env set UXNMR_SAFETY=on", WAIT_TERM);
QUITMSG("--- yb-cest-profile finished ---");
C.2 Hyper-CEST Depolarization Rate Contrast
// AU program "cest-profile"
// for Hyper-CEST profile scan
// use sw_ppm as the saturation frequency in ppm
// this AU program is used with pulse sequence "zgps_hyper_cest"
#include <stdlib.h>
char *envpnt;
int expTime, zgsafety, sleeptime = 20;
int loop_start = 0, loop_stepsize = 200, loop_current=0, loop_end=2000;
GETINT("Choose the starting number of saturation loops:", loop_start);
GETINT("Choose the ending number of saturation loops::", loop_end);
GETINT("Choose the loop incremental stepwidth:", loop_stepsize);
/* Turn zg safety off if on. Turn it back on at the end. */
envpnt = getenv("UXNMR_SAFETY");
zgsafety = 0;
if(envpnt != NULL)
{
if(strcasecmp(envpnt, "on") == 0)
{
zgsafety = 1;
CPR_exec("env set UXNMR_SAFETY=off", WAIT_TERM);
}
}
GETCURDATA;
WPAR("temp_yb","all");
// three blank points to eliminate the starting bias of hp xenon flow
TIMES(3)
system("closeall.exe");
sleep(sleeptime);
SETCURDATA;
123
RPAR("temp_yb","all");
STOREPAR("L 6 ", 0);
system("openall.exe");
ZG;
// auto process current data
EFP;
APK;
XCMD("abs n");
APK;
XCMD("abs n");
APK;
XCMD("abs n");
// go to next data set
IEXPNO;
END
// calculate number of exp based on loop span
// and step size of loop increment
int NumberOfExp=(loop_end - loop_start)/loop_stepsize + 1;
loop_current = loop_start - loop_stepsize;
TIMES(NumberOfExp)
system("closeall.exe");
sleep(sleeptime);
SETCURDATA
RPAR("temp_yb","all");
// change number of saturation loops
loop_current += loop_stepsize;
STOREPAR("L 6 ", loop_current);
system("openall.exe");
ZG;
// auto process current data
EFP;
APK;
XCMD("abs n");
APK;
XCMD("abs n");
APK;
XCMD("abs n");
// go to next data set
IEXPNO;
END
/* Turn zg safety on. */
if(zgsafety == 1)
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CPR_exec("env set UXNMR_SAFETY=on", WAIT_TERM);
QUITMSG("--- yb-cest-loop finished ---");
C.3 Hyper-CEST Data Auto-processing Script
/****************************************************************/
/* yb-multi-int-cest 11/1/2012 */
/****************************************************************/
/* Short Description : */
/* AU program for automatic integration of a series */
/* of 1D spectra with AI calibration. */
/****************************************************************/
/* Keywords : */
/* integration of a series of data sets */
/****************************************************************/
/* Description/Usage : */
/* AU program for automatic integration of a series */
/* of 1D spectra with AI calibration. The spectra can */
/* either be stored in a series of EXPNOs or in a series */
/* of PROCNOs. */
/* The AU program works as follows : */
/* 1. Switch to the first experiment to be integrated. */
/* 2. Define the integral region(s) you want to use */
/* in the interactive integration menu. Calibrate the */
/* integrals with an appropriate calibration factor */
/* (calibrate button) and store the intrng file (write */
/* return button). */
/* 3. Store the intrng file with the ’wmisc’ command */
/* under a name of your choice. */
/* 4. Start the AU program. */
/* The individual integration results are stored in the */
/* file integrals.txt in each dataset, the summary of */
/* all results is stored in the file intall.txt in the */
/* first dataset. */
char intrngfile[256], printname[256];
char intresult[256], intallresult[256], dummystr[256];
/* intallresult is the final output */
int iii, useprocnos=0, curr_loop = 0;
float curr_freq = 0;
FILE *fpnt, *fpnt2;
int integ_number = 0;
float start_ppm = 0, end_ppm = 0, integ_value = 0;
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GETCURDATA
i1 = 4;
GETINT ("Enter first experiment number :",i1)
DATASET(name,i1,procno,disk,user)
i2 = 23;
GETINT ("Enter number of experiments :",i2)
/* Name of integration range, to be applied to all spectra */
(void) strcpy (intrngfile,"cest");
GETSTRING ("Enter name of intrng file :",intrngfile)
RMISC("intrng",intrngfile)
STOREPAR("INTSCL",1.0)
FETCHPAR("CURPRIN",printname)
STOREPAR("CURPRIN","integrals.txt")
LI
STOREPAR("CURPRIN",printname)
(void) sprintf (intresult,"%s/data/%s/%s/%s/%d/pdata/%d/integrals.txt",
disk, user, type, name, expno, procno);
fpnt=fopen(intresult, "r");
if(fpnt==NULL)
{
Proc_err(DEF_ERR_OPT, "No integral result file :\n%s\n\
Maybe CURPRIN is not a filename ?", intresult);
ABORT
}
(void) sprintf (intallresult,"%s/data/%s/%s/%s/%s.txt",
disk, user, type, name, name);
fpnt2=fopen(intallresult, "wt");
if(fpnt2==NULL)
{
Proc_err(DEF_ERR_OPT, "No all-integral result file :\n%s",
intallresult);
ABORT
}
/* Discard first five lines of integral result file */
for (iii = 0; iii < 5; iii++)
fgets(dummystr, 120, fpnt);
/*generate top of table */
(void) sprintf (dummystr,"Chemical shift , CNST20(Hz) , L6 , Expno
, Integral of Xe(aq) peak\n", curr_freq );
fputs (dummystr, fpnt2);
// get saturation frequency in each file (in ppm )
FETCHPAR("CNST 20", &curr_freq)
(void) sprintf (dummystr,"%.2f , ", curr_freq / 138.24 );
fputs (dummystr, fpnt2);
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// get saturation frequency in each file (in Hz )
FETCHPAR("CNST 20", &curr_freq)
(void) sprintf (dummystr,"%.2f , ", curr_freq );
fputs (dummystr, fpnt2);
// get number of cest loops in each file
FETCHPAR("L 6",&curr_loop)
(void) sprintf (dummystr,"%d , ",curr_loop);
fputs (dummystr, fpnt2);
(void) sprintf (dummystr,"%d , ",expno);
fputs (dummystr, fpnt2);
/*
while (fgets(dummystr, 120, fpnt) != NULL)
fputs (dummystr, fpnt2);
*/
fscanf(fpnt, "%d\t%f\t%f\t%f\t\n", &integ_number,
&start_ppm, &end_ppm, &integ_value);
fprintf(fpnt2, "%f\n", integ_value);
fclose (fpnt);
TIMES(i2-1)
IEXPNO
RMISC("intrng",intrngfile)
STOREPAR("INTSCL",-1.0)
FETCHPAR("CURPRIN",printname)
STOREPAR("CURPRIN","integrals.txt")
LI
STOREPAR("CURPRIN",printname)
(void) sprintf(intresult,
"%s/data/%s/%s/%s/%d/pdata/%d/integrals.txt",
disk, user, type, name, expno, procno);
fpnt=fopen(intresult, "r");
if(fpnt==NULL)
{
Proc_err(DEF_ERR_OPT, "No integral result file :\n%s", intresult);
return(-1);
}
/* Discard first five lines of integral result file */
for (iii = 0; iii < 5; iii++)
fgets(dummystr, 120, fpnt);
// get saturation frequency in each file (in ppm )
FETCHPAR("CNST 20", &curr_freq)
(void) sprintf (dummystr,"%.2f , ", curr_freq / 138.24 );
fputs (dummystr, fpnt2);
// get saturation frequency in each file (in Hz)
FETCHPAR("CNST 20", &curr_freq)
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(void) sprintf (dummystr,"%5.2f , ", curr_freq );
fputs (dummystr, fpnt2);
// get number of cest loops in each file
FETCHPAR("L 6",&curr_loop)
(void) sprintf (dummystr,"%d , ",curr_loop);
fputs (dummystr, fpnt2);
(void) sprintf (dummystr,"%d , ",expno);
fputs (dummystr, fpnt2);
/*
while (fgets(dummystr, 120, fpnt) != NULL)
fputs (dummystr, fpnt2);
*/
fscanf(fpnt, "%d\t%f\t%f\t%f\t\n", &integ_number,
&start_ppm, &end_ppm, &integ_value);
fprintf(fpnt2, "%f\n", integ_value);
fclose (fpnt);
END
fclose (fpnt2);
(void) sprintf (text,"--- yb-multi-int-cest finished ---\n\
All results summarized in :\n%s",intallresult);
QUITMSG (text)
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